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Translational research is the process that applies knowledge from basic 
biology to techniques and devices in order to solve critical medical issues. 
Increasingly, in the last decades, the aim of basic and translational research is 
to identify specific cellular and animal models for every single process, 
physiological or pathological, under study. To find out the adequate animal 
model, one of the best approaches is to study the orthologues of human 
genes in different species. Small differences in sequences correlated to 
significant differences in functionality provide fundamental information for 
structure-function studies. This aspect is particularly important in detailing 
the molecular basis of disease and disorders, gathering insights on genotype-
phenotype interaction i.e. on the relationship between sequence and function 
of a given gene. The increase in the number of fully sequenced genomes 
offers important advances in comparative genomics and in translational 
research. The finding that in zebrafish genome there are orthologues for 
most human genes is particularly important. In fact, zebrafish are for many 
aspects an outstanding model organism for high-throughput phenotyping 
and modeling human disease and disorders. However, while the biological 
sequences (nucleic acid or amino acidic sequences) from species can be 
rapidly analyzed and compared with each other, information on the 
biological role of a given gene product can be compared only after a detailed 
functional characterization. With this in mind, the research work of this 
thesis has the aim to understand and compare the function of proteins 
belonging to the SoLute Carrier family 15 member A1 SLC15A1 (PepT1) in 
some fish orthologues. The intestinal transporter PepT1 represents a major 
route of peptides and drug intake. It can mediate the uptake of a large 





molecules and bacterial peptides. Besides the important role of PepT1 in the 
nutrient uptake and sensing, the study of the functional properties of this 
transporter is of great importance not only for the involvement in 
pathological states, but also for its double role in therapeutic approaches. The 
development of drugs that target the intestinal peptide transporter PepT1 has 
become one of the main challenges to circumvent the reduced oral 
bioavailability, which is one of the principal causes of prodrugs failure in 
preclinical and clinical studies. Due to its high expression in intestinal 
inflammatory diseases and in some cancer cells, PepT1 has been also 
suggested as possible target of newly developed nano delivery system like 





















Chapter 1. Introduction 
 
 
Comparative approaches: from comparative genomics to translational 
research 
 
The advances in genomics and next-generation sequencing have provided new 
opportunities for comparative studies by the constant and rapid increasing in 
the number of fully sequenced genomes. The comparative approach is required 
and useful in many fields of basic and translational research. 
New insights into evolutionary, genetic, biochemical, metabolic, and 
physiological pathways are gained by the comparison of entire genomes from 
different species. Comparative genomics allows to better understand how 
species have evolved and to determine the function of genes and noncoding 
regions of the genome. Numerous functions of human genes have been 
identified by examining their counterparts in organism models. 
Moreover, the abundance of genomic information is a great value in 
translational and biomedical research, particularly in the comprehension of the 
molecular basis of human genetic disorders. For instance, animal models can be 
chosen to monitor pathogenesis of human diseases based on explicit gene 
homology. The gene homology is being increasingly leveraged to create 
functional disease models in animals that can help to understand newly 
identified human pathogenic mutations or altered metabolic pathway in order to 
develop of new clinical tools for the diagnosis, for drug discovery and to test the 









Fish species as models in environmental and comparative genomics  
 
In recent years, several fish species have played important roles in deepening the 
knowledge of the vertebrate genome evolution. These studies yielded a great 
number of information on the structure of human genes and provided precious 
insights into the molecular basis of human genetic and disorders. 
Fish represent the most heterogeneous group of vertebrates; they are divided 
into three major superclasses i.e. Agnatha, Chondrichthyes and Osteichthyes. 
This latter superclass consists of a large and diverse subclass called 
Actinopterygii, representing around 95 % of all existing fish species and whose 
majority (almost 99 %) is grouped in the infraclass called teleost fish (Volff, 
2005). 
With more than 30.000 species identified so far (www.fishbase.org), teleost fish 
exhibit extraordinary diversity in morphology, lifestyle and physiology. This 
biodiversity is largely due to peculiar features in their genome (Volff, 2005; Ravi 
and Venkatesh, 2008). During Actinopterygian lineage evolution, a round of 
whole genome duplication led to extensive paralogy among fish genes. 
Paralogue genes have been maintained in teleost genome, thus providing the 
driving force behind the diversification of gene functions and the generation of 
diversity among fish species. Fish offer interesting physiological models of 
response and adaptation to an astonishing range of environmental conditions. 
In aquatic habitat, the intimate physiological contact between fish internal fluid 
compartments and external environment potentially induces a high sensitivity of 
organisms to different water-borne parameters such as: oxygen level, 
temperature, salinity and even pollutants. So, the environmental genomics 
largely employ fish as model to study the organism-environment interface 
though genomic approaches (Cossins and Crawford, 2005). 
While the studies on environmental genomics are useful to better understand 





comparative genomics allow to detail the evolution in vertebrate genome and 
the function of individual genes. 
An interesting application of teleost fish model in environmental and 
comparative genomics is represented by the studies on the SoLute Carrier 
superfamily (SLC), that includes genes for passive transporters, ion-coupled 
transporters and exchangers, which have an important role as 'metabolic gates' 
of cells and mediate the transport of a wide range of essential nutrients and 
metabolites and drugs (Zhang et al., 2019). According to their biological 
significance, the SLC members are conserved throughout evolution, thus the 
comparative approach is a good tool to investigate the relation between 
structural features and functional properties of these transporters. Moreover, the 
major part of these proteins has been recently highlighted for their importance 
as pharmacological targets (Cesar-Razquin et al., 2015). In recent years, 
structural data were obtained by crystal structure and molecular models of SLC 
homologues from a great variety of eukaryotes and prokaryotes. These 
structures provided templates useful in clarifying the substrate specificity of the 
human SLC members (Colas et al., 2016). On a functional perspective, studies 
about features of teleost transporter revealed extraordinary assortment of 
molecular and functional properties, reflecting peculiar protein adaptations to 
the physiology of the species and/or to the environments in which they live. 
The information obtained from teleost fish models are a good tool to clarify 
how human transporters work and what are their essential roles in human 
physiology (Romano et al., 2014). Notably, recent studies on mammals 
suggested that some intestinal SLC transporters important in nutrient uptake, 
have also the role of nutrient sensors (Zietek and Daniel, 2015; Daniel and 
Zietek, 2015). In fish, the intestine is a multifunctional organ not only involved 
in nutrient absorption but also with other physiological role like osmoregulation, 
acid-base regulation and nutrient sensing etc. The study and characterization of 





for human health. In the last decades, the increase in the number of databank 
sequences has revealed progressively that teleost fish SLC genes are duplicated 
(Verri et al., 2017). The presence of duplicated genes provides novel 
opportunities for refining the investigations on regulation and function of 
distinct paralogues. 
The identification of fish orthologues of some mammalian genes highlighted 
that many aspects of developmental pathways, organ system and physiological 
mechanism are conserved (Roest Crollius and Weissenbach, 2005). For instance, 
the basic mechanism involving central and peripheral signaling in the controlling 
appetite has been preserved along the vertebrate evolution, in particular between 
teleost fish and mammals (Soengas et al., 2018). All these aspects made teleost 
fish attractive models for investigating the physiology of appetite control under 
an evolutionary perspective. 
 
 
Fish as models for understanding the vertebrate endocrine regulation of 
feeding 
 
Fish and mammals differ in many aspects of their physiology, particularly in 
terms of metabolic rates, growth patterns and energy storage. Fish show low 
metabolic rate since they are poikilotherms and do not expend energy to 
maintain a constant body temperature (van de Pol et al., 2017); many species 
have indeterminate growth (Volkoff et al., 2009), while others present energy-
demanding foraging behavior to survive during periods of low food availability 
(Ronnestad et al., 2017). In addition to physiological function differences, 
mammals and fish differ in brain and gastrointestinal tract morphologies. These 
organs are involved mainly in homeostatic and hedonic regulation of food 
intake. Despite this, the regulation of food intake is well conserved between 
teleost and mammals since they share similar endocrine signals, mainly 





The homeostatic energy supply in vertebrate is guaranteed by several 
neuroendocrine pathways regulated by a dual signal component: a short term 
and a long term signaling (Figure 1.1). 
 
 
Figure 1.1 Schematic model summarizing the short- and long-term control of energy 




The short-term control of food intake is mediated by central and peripheral 
signals that take place between brain and gastrointestinal tract (Soengas et al., 
2018). The major components of short-term signaling from gastrointestinal tract 
are represented by nutrients and appetite-regulating hormones. Both these 
signals send nutritional information to the control areas in the brain through 
afferent nerves or via systemic circulation. In gastrointestinal tract, the nutrient 
sensing mechanisms lead to the modulation of the secretion of appetite-
regulating hormones by enteroendocrine cells. 
Several appetite regulatory hormones were isolated in some teleost fish species 





counterparts. Among the hormones that induce appetite and food consumption 
(orexigenic function), ghrelin (GHRL) is produced in the stomach of fish (as in 
mammals) or in the intestine of some stomach less species (Ronnestad et al., 
2017). Several studies, conducted on fish, suggested that ghrelin is an appetite 
stimulator (Amole and Unniappan, 2009; Hatef et al., 2015; Tian et al., 2015) 
and a modulator of digestive processes and glucose homeostasis (Blanco et al., 
2017). 
The counterpart of mammalian peptides with food-intake limiting function 
(anoxigenic function) have been also identified in fish. Some of them are 
cholecystokinin (CCK), gastric-releasing peptide (GRP), peptide tyrosine 
tyrosine (PYY) and glucagone like peptides (GLP-1 and GLP-2). Although in 
fish little is known about the detailed mechanisms underlying the physiological 
roles of all these peptides, recent results supported the conservation of 
anorexigenic function of these hormones in the teleost lineage (Ronnestad et al., 
2017). 
The short-term signals from the gut to the brain interact with long-term signals 
that modulate the sensitivity of brain responses to gastrointestinal satiation 
signaling (Cummings and Overduin, 2007). In mammals, the long-term signals 
are primarily humoral. The adiposity hormones, leptin and insulin, communicate 
with the brain in modulating fat stores to the brain and regulate short-term food 
intake to achieve long-term energy balance (Yamada et al., 2006). 
As opposed to mammals which have a single leptin gene expressed in 
subcutaneous fat, many fish species have several leptin gene paralogues 
expressed mostly in liver and intestine (Ronnestad et al., 2017). The presence of 
multiple leptin paralogues in teleosts may underline such a variety of different 
functional properties of leptin in fish (Soengas et al., 2018). While some findings 
suggested that leptin is involved in mobilization of lipid stores in fish, emerging 
data suggest that leptin might be important in other metabolic processes, such 





metabolism and somatic growth (Won et al., 2016; Ronnestad et al., 2017). In 
mammals, insulin is an adiposity signal that conveys fat store information to the 
brain. It has anabolic functions at the periphery and catabolic effects in the 
hypothalamus (Havel, 2001). Whereas the anorexigenic action of insulin and its 
mechanism of action are clear in mammals, the effects of insulin treatment on 
food intake in fish are contradictory (Delgado et al., 2017). 
The regulation of food intake, gastrointestinal physiology and nutrient 
metabolism is also mediated by gut microbiota that refers to the population of 
microorganisms residing in the intestine. Among the possible mechanisms in 
which microbiota acts on the regulation of appetite, is reported the production 
of certain compounds e.g. short-chain fatty acids (SCFAs). These molecules may 
affect the secretion of appetite-regulating hormones by enteroendocrine cells 
(Alcock et al., 2014). The microbiota was shown to influence behavior, feeding, 
digestive functions and metabolism in fish in a species-specific manner (Volkoff, 
2019).  
The dysbiosis, i.e. imbalances in the microbiota, was shown to contribute to 
etiology of several diseases. The role of microbiota was reported in intestinal 
inflammatory disorders such as Inflammatory Bowel Disease (IBD) (Belkaid and 
Hand, 2014); in several autoimmune diseases (Belkaid and Hand, 2014); in Type 
II Diabetes and Metabolic Syndrome (Belkaid and Hand, 2014); in cancer 
(Belkaid and Hand, 2014); in obesity (Cuevas-Sierra et al., 2019) and eating 
disorders (Ruusunen et al., 2019). 
Although gut microbiota of mammal and fish are different, Valenzuela and 
colleagues (Valenzuela et al., 2018) showed that germ free zebrafish larvae could 
be colonized by human gut microorganism. This result together with the similar 
role of microbiota on fish and mammal biology (Teame et al., 2019; Bates et al., 
2007), open an interesting area to study host-microbiota interactions using 






Fish as models in translational research: spotlight on zebrafish 
 
Among teleost fish, zebrafish (Danio rerio) have become the most used 
laboratory model for their main features, such as: small size, the ease of 
breeding, optical clarity of embryos, well-characterized extrauterine 
development, quick maturation, reaching larval stage by 72 hours post-
fertilization, and ease of genetic manipulation. All these features make zebrafish 
very suitable and increasingly used to study developmental biology, and gene 
function (Bradford et al., 2017). In addition, zebrafish have been recognized to 
be valuable vertebrate models for studying human disease and associated 
therapeutics (Deveau et al., 2017; Liu et al., 2016). 
The zebrafish genome contains orthologues for many human genes, as reported 
by the ninth assembly of the zebrafish genome (Zv9), published on 17 April 
2013 (Howe et al., 2013). The comparison with the human reference genome 
showed that 71,4% of human genes have at least one zebrafish orthologue, 
2.601 genes of which (82%) have morbidity descriptions listed in OMIM 
(Online Mendelian Inheritance in Man) (Howe et al., 2013). Moreover, the 
advance in functional genomics techniques, in both forward and reverse 
genetics approaches, has enabled the systematic linkage between genotype and 
phenotype, revealing a lot of genes in zebrafish involved in cell metabolism, 
morphogenesis, tissue homeostasis, organogenesis and cancer progression 
(Fuentes et al., 2018). 
After the identification of human orthologues of annotated protein-coding 
genes in zebrafish, the usefulness of zebrafish as a disease model for 
translational research has increased dramatically. CRISPR/Cas9 technology has 
revolutionized genome editing, representing the most important advances in 
zebrafish disease modelling (Patton and Tobin, 2019). The major advantage 
offered by the technique is the generation of site-specific mutation in genome 





zebrafish provides a powerful platform to improve the knowledge on gene-
phenotype relation (Tessadori et al., 2018) and gene-gene (and even gene-
environment) interactions in human disorders (Patton and Tobin, 2019; Farr et 
al., 2018). Moreover, it enables the rapid testing of candidate disease genes 
identified through human genetics (Ton et al., 2018). 
The zebrafish has also emerged as a particularly useful system for studying the 
tissue inflammation and infection. Notably, zebrafish has been recently used as a 
model to study intestinal inflammation for its transparent body (Teame et al., 
2019). Oehlers and coworkers successfully used zebrafish to study the 
susceptibility genes and host-microbe interactions in IBD (Oehlers et al., 2011a; 
Oehlers et al., 2011b). 
A fascinating area in recent and rapid expansion that shows zebrafish as 
powerful model organism, is the study on the role of metabolism in obesity, 
disease (including dyslipidaemia, diabetes and fatty liver disease), and tumor. 
A major strength of studying obesity in zebrafish is the ability to use fluorescent 
probe to identify genes involved in defects of lipid metabolism in vivo (Farber et 
al., 2001). Several obesity models were developed in zebrafish using changes in 
diet or genetic manipulations such as modifications of genes encoding appetite 
hormones or metabolic pathways (Zang et al., 2018). Taken together, diet-
induced and genetic-induced models provided an in vivo system in which it is 
possible to study the environmental, physiological and genetic basis of obesity 
and to screen new developed drugs to treat obesity (Zang et al., 2018). 
For diabetes modelling, although an appropriate model to study diabetes long 
term effect is still lacking in zebrafish, the disease complications such as diabetic 
retinopathy (Jung et al., 2016) and changes in bone metabolism (Carnovali et al., 
2016) were investigated using long immersion of larval or adult zebrafish in 






To investigate cancer progression, zebrafish have emerged as powerful platform 
due to the close resemblance at molecular and anatomical level between 
zebrafish models of cancer and human tumors. Different techniques develop 
zebrafish models of cancer either by exposure to carcinogens or due to genetic 
mutation of tumor suppressor genes or introduction of an oncogene (Santoriello 
and Zon, 2012). Dysregulation of metabolism is a central driver of several 
diseases and cancer types. In tumor progression the metabolism reprogramming 
is well-known and established hallmark event (Hanahan and Weinberg, 2011); 
the most well-described metabolic change is the Warburg effect in which cancer 
cells increase glucose uptake and glycolytic activity (Vander Heiden et al., 2009). 
Several studies suggested the efficacy of zebrafish tumor models to yield new 
insights on the molecular mechanisms of the Warburg effect (Sandoval et al., 
2017; Shtraizent et al., 2017). Recently, zebrafish models of melanoma revealed 
that the Warburg effect is a cancer “archetype” (i.e. co-opted cellular state) that 
emerges during the tumor progression (Baron et al., 2018). 
Emerging studies that used zebrafish as a model system are focused on the 
integration of metabolomics and transcriptomics methodologies to illuminate 
the mechanism underlying metabolic dysfunction of disease and metabolic 
reprogramming of tumor (Salmi et al., 2019). 
In the field of drug discovery and development, the tissue-specific distribution 
of molecules is important for disease treatment. In this regard, the body 
transparence of zebrafish gives more benefits in pharmacokinetics study, 
particularly in investigating the drug distributions in the context of the whole 
animal. By the screening of a large panel of fluorescent molecules, Yao and 
coworkers found 15 molecules that showed a tissues-specific distribution in 
zebrafish larvae (Yao et al., 2017). Among these molecules, two structurally 
similar chemotherapeutic compounds, doxorubicin and epirubicin, were 
observed to have distinct distribution preferences. Notably, the liver-specific 





a zebrafish model of hepatic hyperplasia (Yao et al., 2017). This and many other 
studies suggest that zebrafish is a powerful model in drugs discovery and 
development. Moreover, these studies provided a novel approach for 
understanding how to minimize off-target toxicities and may have important 
implications for drug efficacy (Patton and Tobin, 2019). 
 
 
SoLute Carrier transporters (SLC) 
 
The cells control the movement of many substrates across plasma and inner 
membranes by membrane integral proteins: channels, pumps and transporters. 
Their roles are importing and exporting molecules, including water, ions, 
nutrients, vitamins, cofactors, and many drugs across the lipid bilayer. All these 
roles are fundamental for cellular homeostasis. Transport proteins can be 
involved in active and passive transport system which generate ion gradients 
across membranes, employing different energy-coupling mechanisms. These 
systems are defined as primary- or secondary-active transport systems. ATP-
binding cassette (ABC) transporters and ion pumps (ATPases) are primary-
active. Ion pumps hydrolyze ATP to pump ions as Na+, K+, H+, Ca2+ against 
their electrochemical gradient across the lipid bilayer, in/out of cells or 
organelles. Ion gradients are used to drive uphill transport processes across 
biological membranes. On the other hand, passive transporters (facilitated 
transporters) allow passage of solutes according to their gradient. In 2004, the 
definition of SLC (SoLute Carrier) was introduced to define the genes encoding 
passive transporters and secondary active transporters: ion coupled symporters 
and antiporters. A membrane protein has been assigned to a specific SLC family 
if it has at least 20-25% amino acid sequence identity to other members of that 
family (Hediger et al., 2004). The SLC classification was then used for solute 





After the G-protein-coupled receptors (GPCRs), SLCs are the second-largest 
family of membrane proteins in the human genome (Hoglund et al., 2011). The 
HUGO (HUman Genome Organisation) Gene Nomenclature Committee 
(HGNC) provides a list of transporter families of the SLC gene series 
(www.genenames.org). According to the current counting 
(www.bioparadigms.org), human SLC genes include over 400 members, 
distributed in 65 subfamilies based on their sequence similarity (Hediger et al., 
2013) (www.bioparadigms.org). In line with the classification of the human 
genes, teleost fish genes for SLC-type transporters have been collected 
preliminarily in the GenBank database (Dec 2010–Mar 2011) and classified in 
more than 50 families (Verri et al., 2012). The most relevant species are 
zebrafish with 304 genes identified, followed by Atlantic salmon (Salmo salar) 
with 53 genes. According to the whole-genome duplication, several SLC genes 
are duplicated in teleost fish. Moreover, in salmonids genome, where 
independent events of polyploidization were detected (Volff, 2005), probably 
more than two copies of the same SLC gene could be found. 
Despite their non-uniform distribution, SLC are globally expressed throughout 
the body and in human are highly expressed in kidney, brain, liver, gut, and 
heart, where they mediate the transport of a wide spectrum of essential nutrients 
and metabolites across cellular or subcellular compartments, consistently with 
the tissue metabolic characteristics. The transported substrates include glucose, 
amino acids and small peptides, fatty acids and lipids, vitamins, 
neurotransmitters, inorganic/metal ions and many other solutes. Current 
research focuses on the roles of SLC transporters in nutrient and metabolic 








SoLute Carrier 15 family (SLC15) 
 
The digestion and uptake of dietary proteins in the intestinal lumen are mainly 
in the form of free amino acids and small peptides. After intestinal absorption, 
the amino acids and small peptides reach the systemic circulation to be delivered 
to various tissues as energy metabolites or resources for protein synthesis. While 
free amino acids are absorbed via several kinds of SLC transporters (Broer, 
2008), the di- and tripeptides are solely transported by the SoLute Carrier 15 
family (SLC15) (Spanier, 2014), also referred to as the Proton coupled 
Oligopeptide Transporters family (POT) (Paulsen and Skurray, 1994)  or 
Peptide Transport Family (PTR). Originally discovered in bacteria (Hagting et 
al., 1994), members of the SLC15 family were found in all kingdoms of life, with 
the exception of the Archaea (Newstead, 2017a). 
The SLC15 family includes four known members in vertebrates (Daniel and 
Kottra, 2004). PepT1 and PepT2 (encoded by SLC15A1 and SLC15A2 genes, 
respectively) are oligopeptide transporters. Pht1 and Pht2 (encoded by 
SLC15A4 and SLC15A3 genes, respectively) are peptide/histidine transporters. 
Finally, a putative fifth member of SLC15 family is reported, the SLC15A5, 
which is partially known in sequence but unknown in function (Sreedharan et 
al., 2011). 
While many studies evaluated the implications of PepT1 and PepT2 in biological 
processes, few investigations are focused on the peptide/histidine transporters 
up to now. 
Primary sites of the functional expression of PepT1 and PepT2 are the intestine 
and kidney, respectively. Additionally, other localization sites have been 
identified, including bile duct epithelium, pancreas and liver for PepT1, and 
brain, lung and mammary gland for PepT2 (Viennois et al., 2018). In the apical 
surface of epithelial cells, PepT1 represents the low-affinity/high-capacity 
system and it is the main route for dietary peptide uptake. PepT2 on the other 





selective transport. PepT1 and PepT2 are proton coupled symporters, thus their 
function is strictly dependent on the transmembrane proton electrochemical 
gradient. PepT1 and PepT2 mediate the uptake of a large number of substrates 
(400 different dipeptides, 8000 different tripeptides) (Brandsch et al., 2008; Vig 
et al., 2006) and many peptidomimetic compounds, β-lactam antibiotics, 
selected ACE inhibitors and renin inhibitors, as well as antiviral and anticancer 
drugs (Spanier and Rohm, 2018; Brodin et al., 2002). 
Pht1 and Pht2 were initially cloned from the brain (Yamashita et al., 1997; 
Sakata et al., 2001), but they resulted to be expressed in a variety of tissues 
including spleen and thymus, intestinal segments, eye and lung (Viennois et al., 
2018). Pht1 and Pht2 were identified subcellularly rather than in the plasma 
membrane, thus they are considered endosomal/lysosomal transporters (Song et 
al., 2018). Due to their subcellular localization, the driving force, the transport 
mode and the substrate specificity have not been analyzed systematically for 
these two transporters. The functional characterization of the rat Pht1 
transporter (Yamashita et al., 1997) and of the human Pht1 transporter 
(Bhardwaj et al., 2006) showed an increasing in the uptake of substrate in the 
presence of a proton gradient. This observed pH dependence suggested that the 
peptide/histidine transporters have a similar electrogenic mode of operation as 
it occurs for the PepT-type proteins (Daniel and Kottra, 2004). Nevertheless, 
even though Pht1 and Pht2 can transport di- and tripeptides, it is unknown 
whether they can transport the same wide substrate spectrum of PepT1 and 
PepT2. In contrast to oligopeptide transporters, Pht1 and Pht2 are reported to 
accept free L-histidine as substrate and currently they are considered the high 
affinity transporters for histidine and histidine-containing dipeptides, such as 
carnosine (β-alanine-L-histidine) and carnosine-like molecules (Yamashita et al., 
1997; Sakata et al., 2001). 
Among the SoLute Carrier 15 family, PepT1 transporter is deeply studied in 





transporters in teleost fish due to its major physiological role in protein 






PepT1 gene cloning and tissue expression 
 
In 1994, the complementary DNA coding for the rabbit PepT1 was cloned 
screening an intestinal cDNA library, expressed in Xenopus laevis oocytes and 
used for uptake studies of 14C-labelled glycyl-sarcosine (Fei et al., 1994). 
Subsequently, PepT1 was isolated by expression and genomic cloning from 
other mammalian species such as human (Liang et al., 1995), rat (Saito et al., 
1995), mouse (Fei et al., 2000), sheep, cow, pig (Chen et al., 1999) and macaque 
(Zhang et al., 2004a). 
The first teleost fish PepT1 transporter was cloned from zebrafish in 2003 
(Verri et al., 2003). The electrophysiological characterization in X. laevis oocytes 
showed that zebrafish PepT1 was able to mediate substrate transport as a low 
affinity/high capacity system (Verri et al., 2003). Later, cDNA sequences of 
PepT1 transporters were cloned and functionally characterized from European 
see bass (Dicentrachus labrax) (Sangaletti et al., 2009), Atlantic salmon (Salmo salar) 
(Ronnestad et al., 2010) and Antarctic icefish (Chionodraco hamatus) (Rizzello et 
al., 2013), providing the basis of functional comparison among teleost fish 
orthologues and among teleost and mammalian orthologues. Although detailed 
kinetic characterization in X. laevis oocytes was carried out only for few PepT1 
proteins in fish, the presence of a low affinity type peptide transporter was 
described in intestinal brush border membrane of both omnivorous (Reshkin 
and Ahearn, 1991) and carnivorous teleost species (Maffia et al., 1997; Verri et 





related nucleotide sequences of many teleost species became available in 
databank as annotated or predicted by computational analysis (Romano et al., 
2014). 
The analyses on fully completed genomes of zebrafish and pufferfish (Tetraodon 
nigroviridis) allowed Goncalves and coworkers to identify another PepT1-like 
gene, thus providing the first evidence of the presence of two PepT1 genes in 
teleost fish genome (Goncalves et al., 2007). The two genes were named slc15a1a 
and slc15a1b, and their encoded proteins were designated as PepT1a and 
PepT1b, respectively. According to the designation reported by Romano et al. in 
2014, the characterized transport activity in functional studies reported in many 
papers has been generally indicated as “PepT1”, nevertheless it must be actually 
ascribed to PepT1b proteins. Consequently, functional data deriving from 
PepT1a transport proteins are still lacking (Romano et al., 2014). 
In mammals, PepT1 is mainly expressed in enterocytes of small intestine and in 
renal proximal tubular cells of the S1 segments. Furthermore, PepT1 expression 
is also detected in the pancreas, bile duct, liver (Daniel, 2004; Daniel and Kottra, 
2004; Gilbert et al., 2008; Smith et al., 2013) and a little or no expression is 
found in healthy distal colonic epithelium (Wuensch et al., 2013). 
In teleost fish, PepT1 is principally expressed in the intestine with very low 
extent in kidney, liver, spleen and other organs and tissues (Romano et al., 
2014). The primary targets of PepT1 expression in intestine are the pyloric 
caeca, if present, and foregut (Wang et al., 2017). However, patterns of 
expression along the intestine are diverse across multiple fish species (Romano 
et al., 2014). As a matter of fact, PepT1 expression is confined at the most 
proximal portions in zebrafish, carps and pufferfish; is uniform in proximal and 
distal regions in cods and killifish; decreases from proximal to distal intestine 
portions in salmon, trout, sea bass and sea bream (Romano et al., 2014; Verri et 
al., 2017). Moreover, the spatiotemporal mRNA expression of PepT1 in 





response to different solicitations such as nutritional states (Bucking and 
Schulte, 2012; Ronnestad et al., 2010; Liu et al., 2013; Con et al., 2017), dietary 
challenges (Goncalves et al., 2007; Liu et al., 2013) and environmental 
conditions (Bucking and Schulte, 2012; Con et al., 2017). 
In 2012 Burking and Schulte detected for the first time that the expression of 
PepT1a and PepT1b mRNAs occurred contemporarily in mummichog (Fundulus 
heteroclitus) intestine but this result was environmental-specific. The expression 
analysis revealed that while both paralogues were expressed in freshwater fish, 
only PepT1b expression was detectable in seawater acclimated fish (Bucking and 
Schulte, 2012). Also, it has been shown that fasting and re-feeding induced 
changes in expression of both paralogues in mummichog, showing: up-
regulation after short-term fasting (following 3 days of fasting), down-regulation 
after prolonged fasting (following 21 days) and up-regulation (above pre-fasted 
levels) after resumption of feeding (following 7 days of re-feeding) (Bucking and 
Schulte, 2012). 
Regarding the intestinal tract distribution of PepT1a and PepT1b, their 
expression was uniform in mummichog, while Huang and coworkers reported 
that PepT1a-to-PepT1b ratio was inverted, passing from proximal to mid 
intestine in Nile tilapia (Oreochromis niloticus) (Huang et al., 2015). 
A more recent study on Mozambique tilapia (Oreochromis mossambicus) intestine 
showed that both PepT1 genes were expressed in anterior and middle tracts of 
freshwater and seawater acclimated fish (Con et al., 2017). After 6 hours of 
feeding, the regulation of expression along the intestine changed according to 
the environmental conditions: in freshwater fish it was shown an upregulation 
about 5-fold higher in anterior tract that in the middle intestine, whereas in 
saltwater fish the expression was almost equal between the two analyzed tracts 
(Con et al., 2017). 
Expression patterns differ largely from species to species, making the unique 





reported studies revealed the plasticity of PepT1a and PepT1b expression as 
response to dietary challenges and environmental salinity conditions. Overall, 
these data suggest that the PepT1a transporter might be expressed and operate 
at intestinal level in parallel or coupled to the PepT1b transporter (Verri et al., 
2017). 
Hence, to understand the role of each transporter in fish physiology, different 
steps need to be taken, namely the assessment of their local distribution along 
the intestine, their expression patterns in the different tissues and organs and 
their transport properties. 
 
 
Molecular structure of PepT1 transport proteins 
 
PepT1 proteins display a high degree of homology across species (e.g. about 
60% similarity at protein level between rabbit PepT1 and zebrafish PepT1b). 
The length of the protein is about of 700 amino acids in higher vertebrates 
(human and rabbit PepT1 are proteins of 708 and 707 amino acids, respectively) 
and it is usually longer in most of the lower vertebrates, such as in teleost fish 
where PepT1 transporter consists of 718 amino acids for zebrafish, 728 amino 
acids for European sea bass and 734 amino acids for Atlantic salmon (Wang et 
al., 2017). 
The membrane topology of PepT1 was proposed for the first time in studies on 
the rabbit transporter (Fei et al., 1994). The classical hydropathy plot suggested 
that PepT1 consists of 12 transmembrane domains (TMDs) with a long 
extracellular domain (ECD) between TMD 9 and 10. This consensus model was 
partly confirmed for human PepT1 by epitope tagging analyses (Covitz et al., 
1998). The structural features of PepT1 are highly conserved among vertebrates 
(Figure 1.2) and include: 12 TMDs with intracellular both C- and N- termini; a 





proton/oligopeptide symporter signatures; a large extracellular loop between 




Figure 1.2 Topology diagram of human PepT1 with transmembrane helices colored blue to red 
including the position of the extracellular domain between TMD 9 and 10. The locations of the 
conserved sequence motifs within the TMDs are shown (Newstead, 2015). 
 
 
Before the crystallization of PepT1 homologue (Newstead et al., 2011), several 
groups proposed a putative structure model of PepT1 based on computer 
modelling methods (Bolger et al., 1998; Yeung et al., 1998; Lee et al., 1999; 
Meredith and Price, 2006; Pedretti et al., 2008). 
Although there is no three-dimensional protein structure of a vertebrate peptide 
transporter available yet, many structural features can be deduced from 
crystallized bacterial homologues. 
The full structure of a proton dependent oligopeptide transporter was 





family members (Parker and Newstead, 2014; Sun et al., 2014). The atomic 
resolution structure of transmembrane domains in various crystalized 
conformations allowed to obtain an insight on the distinct states of transport 
cycle (Newstead, 2015). All bacterial structures revealed the canonical 12 TMDs 
arranged equally into an N- and C-terminal bundle and two additional 
transmembrane helices, A and B, that form a hairpin-like structure inserted 
between TMD 6 and 7 (Newstead et al., 2011). POT transporters were 
proposed to transport substrates via the rocker-switch mechanism. The N- and 
C- bundles form a “V” shaped transporter that oscillates back and forth from an 
outward to an inward facing state along the pseudo two-fold symmetry axis 
running perpendicular to the membrane plane (Colas et al., 2016). To transport 
di- and tripeptides across the membrane, the transporter must undergoes to 
conformational changes (Figure 1.3), which comprise 4 states. An outward 
open state (step 1 in Figure 1.3) in which the transporter is ready to interact 
with substrate and driving ion(s). An outward open state with substrate and 
driving ion(s) bound (step 2) that switches the transporter into an occluded state 
(step 3) which is followed by an inward open conformation and by the release of 
the substrates and ion(s) into the cell (step 4). Finally, the empty transporter 



















The first crystal structure was determined in 2011, from the bacterium Shewanella 
oniedensis (PepTSo) (Newstead et al., 2011). PepTSo was crystalized in the 
asymmetric inward-occluded conformation revealing two gates, the extracellular 
gate (formed by TMDs 1, 2, 7 and 8) and the intracellular gate (formed by 
TMDs 4, 5, 10 and 11). The gates are responsible of controlling the access to 
the central cavity where peptide-binding site is located. The interaction between 
these gates occur through residues that are conserved across the POT family 
proteins. These residues are involved in two salt bridge interactions positioned 
above and below the main peptide binding site. The structures of Streptococcus 





(Doki et al., 2013) were captured in the inward open state revealing the residues 
involved in salt bridge interactions that appeared to mediate the opening and 
closure of the extracellular and intracellular gates in response to proton and 
peptide binding. 
The closed state of the intracellular gate is stabilized by the salt bridge 
interaction that is made by highly conserved residues, a lysine on TMD 4 and a 
glutamate on TMD 10. On the extracellular gate, the residues involved in the 
interaction are less conserved. In PepTSt and GkPOT the interaction is through 
an arginine on TMD 1 to a conserved glutamate on TMD 7. In PepTSo and in 
“mammalian-like” bacterial POT members, the interaction involves a conserved 
histidine on TMD 2 combined with an arginine-aspartate salt bridge on TMD 1 
and TMD 7 (Newstead, 2017; Parker et al., 2017). A further highly conserved 
domain in the POT family is represented by the ExxER motif on TMD 1 that 
plays a key role in proton binding (Newstead, 2017; Longo et al., 2018). 
While the structural differences observed in crystallographic models provide 
information about the structural basis for mechanism of POT transporters, 
many mechanistic details remain uncharacterized. In fact, the absence of 
outward- facing experimental models prevent to elucidate the conformational 
transitions occurring between the inward- and outward-facing states. 
Through multiscale molecular dynamic (MD) simulations from the high 
resolution crystal structure of a “mammalian-like” bacterial POT family 
transporter from Xanthomonas campestris, PepTXc, Parker and collaborators 
revealed that the binding of proton to the histidine on TMD 2 facilitates the 
reorientation of the transporter from the inward- to outward- facing state 
(Parker et al., 2017). Based on these results, Parker and coworkers proposed a 
model of the alternating access for proton coupled peptide transport by the 






Figure 1.4 Alternating access model of proton coupled transport by the “mammalian-like” POT 
proteins. Transport is predominantly controlled through the opening and closing of two gates 
that sit on both side of a central binding site. The ExxER motif on TMD 1 is indicated. The 
extracellular cavity created in the inward-facing state allows protonation the TMD 2 histidine 
from the extracellular side resulting in the reorientation of the transporter to the outward facing 
state (Parker et al., 2017). 
 
 
According to the proposed model, the extracellular cavity created in the inward-
facing state (step 4 in Figure 1.4) allows to protonate the histidine on TMD 2 
from the extracellular side. The protonation destabilizes the extracellular gate 
resulting in the reorientation of the transporter from the inward- to the 
outward-facing state (step 4→1 in Figure 1.4). 
Data indicate that the mechanism for proton coupling within the POT family 
can be divided into two types: one that contains the conserved histidine in TMD 





another without the histidine residue in TMD 2, which includes PepTSt and 
GkPOT. 
Recently Batista and coworkers performed a series of adaptive biasing force 
(ABF) molecular dynamic simulations of PepTSt to map the conformational 
free energy profile of the transporter in the presence or absence of ligand and 
protonation (Batista et al., 2019). The results revealed that both proton and 
ligand significantly changed the conformational free-energy profile of PepTSt. 
In the absence of ligand and protonation, the transporter is able to shift 
between inward-open and occluded states only. The protonation of the 
conserved glutamate on TMD 7 acts on the link that determines extracellular 
gate, permitting to the transporter to change the conformation and to come 
back to the outward-open conformation. Ligand binding, on the other hand, 
stabilizes the transporter in the occluded conformation (Batista et al., 2019). 
The occluded state structures of bacterial POT family members, crystallized in 
complex with several peptides, provided important insight into the transporter 
biochemical basis for peptide binding and substrate selectivity (Lyons et al., 





In the intestine of vertebrates, the H+-dependent oligopeptide transporter 
PepT1 is expressed in differentiated enterocytes and in L-enteroendocrine cells 
with distinct localization in the apical plasma membrane (Figure 1.5). PepT1 
represents the major route of di- and tripeptides absorption in intestine. Beside 
its nutritional role, recent functional studies in mammalian enteroendocrine cells 
hypnotized an additional role of PepT1 as transceptor: a transporter/sensor of 

























Figure 1.5 Schematic diagram displaying PepT1 transporter in its nutritional role in intestinal 




PepT1 nutritional role 
 
As primary means of absorption of small peptides, PepT1 has an important 
significance in nutritional physiology. Due to the direct correlation between 
dietary protein availability and accretion of body weight, fish are an outstanding 
model for studying the role of PepT1 on the peptide absorption and the effect 
of protein diets on the animal growth (Verri et al., 2011). 
Following apical influx via PepT1, di- and tripeptides are sequentially hydrolyzed 
by cytosolic hydrolases in free amino acids that reach the systemic circulation via 
different basolateral transport systems. The efflux of not-hydrolized peptides 
can be mediated via basolateral peptide-transporting systems not yet identified 
on a molecular basis (Daniel, 2004). 
PepT1 transporters operate as Na+-independent and H+-dependent system. 





gradient, which is the driving force of the substrate translocation across 
membranes. The proton electrochemical gradient is granted by the apical 
sodium-proton exchanger NHE3. Sodium influx via NHE3 is compensated by 
export through the basolateral Na+/K+ ATPase and potassium ions taken up 
leave the cell by the potassium channels (Daniel and Kottra, 2004). 
PepT1 mediates an enantioselective transport with a variable proton to substrate 
(H+: S) stoichiometry for the uptake of neutral and charged peptides. 
Irrespectively to the substrates net charge, the uptake of di- and tripeptides is 
associated with proton translocation, thus the transport is always electrogenic 
(Daniel and Kottra, 2004). Given its rheogenic activity, the functional properties 
of this transport system can be examined using electrophysiological techniques. 
 
 
Electrophysiological properties of PepT1 
 
The Two Electrode Voltage Clamp technique (TEVC) applied in combination 
with a PepT1 over-expression in X. laevis oocytes, resulted in precise 
electrophysiological measurements, thus revealing detailed features in the 
transporter kinetic mechanism. 
PepT1, as most cotransporters, displays two types of electrical activity: 
transport-associated currents recorded in the presence of substrate, and 
transient pre steady-state currents generated by charge relocation during voltage 
steps in the absence of organic substrate (Mager et al., 1993). The 
electrophysiological approach allowed functional data collection of both 
transport-associated and pre steady-state currents of many PepT1 orthologues 
(Mackenzie et al., 1996b; Nussberger et al., 1997; Sangaletti et al., 2009; Renna et 
al., 2011b). These data were collected under the same experimental conditions, 
e.g. substrate type or concentration, external condition of pH and temperature, 





on kinetic parameters, pre steady-state currents and substrate specificity were 
compared in response to the change of physiochemical parameters (pH, 
temperature and membrane potential), teleost fish PepT1 exhibited unexpected 
functional properties respect to the mammal counterpart (Verri et al., 2017; 
Renna et al., 2011b). 
pH dependence- In many functional studies PepT1 was reported to be pH 
dependent, with an increase of the uptake of transported substrate reaching the 
optimum pH range from 5.0 to 6.0 in heterologous expression system. In 
general, in mammalian PepT1 the change of external proton concentration from 
alkaline to acidic pH increased the transporter apparent affinity without 
affecting the maximal transport rate (Kottra and Daniel, 2001). Notably, in the 
human transporter both apparent affinity and transport rate were increased by 
acidification of external pH (Mackenzie et al., 1996a). Interestingly, with the 
functional characterization of teleost PepT1, it was noticed that whereas the 
increase in apparent substrate affinity for decreasing pH was conserved between 
mammals and fish, the pH effect on the maximal transport rate in the tested 
orthologues was not always similar to mammalian transporters (Verri et al., 
2017). No significant effect of pH was observed on the maximal transport rate 
in PepT1 of European sea bass (Sangaletti et al., 2009) and Antarctic icefish 
(Rizzello et al., 2013). Conversely, the functional characterization of the 
zebrafish transporter highlighted an unexpected increase of maximal transport 
rate at alkaline extracellular concentration (Verri et al., 2003), which was 
observed slightly in Atlantic salmon transporter too (Ronnestad et al., 2010). 
The authors postulated that the peculiar pH dependence shown by zebrafish 
PepT1 could be explained by two complementary anatomical-physiological 
scenarios: the agastric state of zebrafish and the most likely lack of the 
functional interaction between PepT1 and the sodium-proton exchanger in the 





In addition, external pH affected pre steady-state currents of PepT1 as emerged 
by electrophysiological and biophysical analysis of both mammalian (Nussberger 
et al., 1997) and fish transporters (Sangaletti et al., 2009; Renna et al., 2011b).  In 
2011, Renna and coworkers compared pre steady-state currents recorded from 
the rabbit transporter to those from two different teleost fish species (European 
sea bass and zebrafish), using the same experimental setup (Renna et al., 2011b). 
The data showed that the pre steady-state currents of the fish transporters were 
similar while rabbit transporter differed by having slower-decaying currents, this 
was ascribed to different operating temperature of the different orthologues 
(Bossi et al., 2012). Nonetheless, all PepT1 orthologues were similarly affected 
by external pH, showing acidity-induced slowing of pre steady-state currents. 
The analysis was extended to calculate the unidirectional rate constants of 
charge movement in the membrane electrical field and their dependence on 
external pH. The results suggested that an increase in external protons slowed 
down both inward and outward charge movements in all the PepT1 proteins of 
the examined species. All these data allowed the authors to propose a unified 
model that explained electrophysiological properties of each PepT1 orthologue 
and their different behaviors in term of pH dependence. This model included a 
transition state in which the transporter binds the H+ in an allosteric site. The 
fixing of the transporter in this protonated state may explain then the decrease 
in inward rate of positive charge movement caused by acidic pH observed in all 
tested PepT1 orthologues (Renna et al., 2011b). Even if this putative allosteric 
site still remains unknown, it is believed that it could be the cause of the smaller 
transport current observed at acidic pH in the zebrafish PepT1 (Verri et al., 
2003; Verri et al., 2017). 
Transport of differently charged substrates- One of the unsolved question in the study 
of PepT1 transport mechanism, is how the transporter is able to translocate 





In 1997, Stell and colleagues proposed a model to explain the stoichiometry of 
neutral and charged dipeptides transported by rabbit PepT1 expressed in X. 
laevis oocytes (Steel et al., 1997). Based on the rate of intracellular acidification, 
the initial uptake rates of radiolabelled peptides and the associated charge fluxes, 
the resulting proton-substrate coupling ratios were:  1:1 for neutral dipeptides, 
2:1 for anionic dipeptides and 1:1 for cationic dipeptides. After 5 years, Kottra 
and coworkers refined the previous model, demonstrating that the binding 
domain of PepT1 is asymmetric and selective for cationic dipeptides according 
to the location of the charged side chain within the substrate molecule (Kottra 
et al., 2002). Notably, when the charged residue was provided in an amino-
terminal position the substrate was transported in both zwitterionic and positive 
charged form; conversely when the charged residue was provided in carboxyl-
terminal position only the neutral form was transported. Anionic dipeptides 
were transported in their neutral form, but a minimal fraction of them could be 
transiently protonated in the close proximity of the cellular membrane and thus 
they were translocated virtually as charged species with proton-substrate 
coupling ratio of 2:1. 
The proposed model, in Figure 1.6, explained the transport characteristics 
observed in rabbit PepT1 transporter when the positive charge substrate, lysine-
glycine (Lys-Gly), was tested using TEVC technique and compared to the 
zwitterionic substrate, glycine-glutamine (Gly-Gln). At pH 7.5 when lysine-
containing peptide was in neutral form for 17%, the maximal relative current of 
Lys-Gly was higher (168%) than that of Gly-Gln (100%) but it decreased to 






Figure 1.6 A scheme for the transport of charged dipeptides by PepT1 (Kottra et al., 2002). 
 
 
These data were not confirmed for the reversed substrate, glycine-lysine (Gly-
Lys), that at pH 7.5 showed an amount of 17% of molecules recognized by the 
transporter in contrast to 100% of the Lys-Gly molecules (Kottra et al., 2002). 
In teleost fish, differently charged dipeptides were tested for the first time with 
the zebrafish PepT1 (Verri et al., 2009). The data on the kinetic parameters in 
the presence of lysine-containing dipeptides, i.e. Lys-Gly and Gly-Lys, and of 
aspartic (Asp)-containing substrates, i.e. Asp-Gly and Gly-Asp, showed that also 
for the zebrafish PepT1 transporter the position of the charged side chain 





Interestingly, with respect to the current generated by Gly-Gln (100%) in the 
zebrafish transporter the maximal relative current of Lys-Gly increased from 
126% at pH 7.5 to 220% at pH 8.5. In presence of Gly-Lys the maximal relative 
current with respect to Gly-Gln was 94% at pH 7.5 and increased at 191% at 
pH 8.5. 
Uptake of dipeptides containing essential amino acid (EAA)- Later studies on PepT1 of 
different teleost species focused on the transport kinetic of substrates composed 
by lysine (Lys) and/or methionine (Met) for the importance of these molecules 
in animal nutrition. These two EAAs are known to impact body metabolism in 
general and to be crucial in growth performances in vertebrate and particularly 
for teleost fish (Verri et al., 2017). To determine similarities and differences in 
the uptake of substrates containing methionine and/or only lysine, the kinetic 
properties of one mammalian transporter (rabbit PepT1) and two PepT1s from 
different teleost species (European sea bass and zebrafish) were collected and 
systematically compared (Margheritis et al., 2013). 
In rabbit and sea bass transporter, the Lys- and Met- contained dipeptides (i.e. 
Lys-Gly and Lys-Met) showed higher currents than the reference current of the 
zwitterionic substrate, (Gly-Gln). In zebrafish PepT1, all tested dipeptides 
showed comparable currents which were in general smaller than that generated 
by the Gly-Gln, with the exception of Lys-Lys that at more negative potentials 
evoked a higher current. In rabbit and sea bass, the Lys-Lys dipeptide was 
instead only modestly transported. Interestingly, Atlantic salmon PepT1 
conformed more to European sea bass transporter, and also to mammalian 
model, than to zebrafish transporter model. In fact, when tested in Atlantic 
salmon PepT1 arginine-lysine (Arg-Lys), which is structurally similar to Lys-Lys, 
was found having the lowest value of transport efficiency among the tested 
lysine-containing substrates (Ronnestad et al., 2010; Verri et al., 2017). 
Taken together, the comparative functional analysis between mammal and fish 





basis of their differences in functional properties and thus could be the starting 
point of further investigation. Considering the results obtained from the 
molecular modeling (Pedretti et al., 2008), the sequence comparisons allowed to 
identify residues that may account for the different behavior of PepT1 
orthologues. For instance, this approach led Margheritis and colleagues to the 
identification in the TMD 8 of the zebrafish transporter of an amino acid 
substitution, that was relevant for its particular behavior with respect to rabbit 
and seabass transporters (Margheritis et al., 2013). This amino acid substitution 
involved a threonine (Thr) that is substituted with an isoleucine (Ile) in PepT1 
of zebrafish (Ile334Thr). Functional data highlighted the role of this residue in 
transporter substrate selectivity, affinity and consequently transport efficiency. 
The multiple alignment of the PepT1b and PepT1a amino acid sequences from 
some teleost fish allowed to find the Thr-to-Ile substitution in three sequences 
of PepT1a from five representative species throughout the East African haplo-
tilapiine lineage (Verri et al., 2017). However, this substitution was not present 
in the PepT1b sequence of the same species. This evidence led the authors to 
the hypothesis that after gene duplication the retained duplicated gene may have 
diverged in function through sub- or neofunctionalization (Verri et al., 2017). 
 
 
PepT1 enteroendocrine role 
 
In the gastrointestinal tract, 1% of the total epithelial cell population is 
represented by enteroendocrine cells (EECs) that form the largest endocrine 
organ in the body. EECs are specialized cells capable of sensing luminal content 
and releasing signaling molecules that can modulate a variety of physiological 
and homeostatic functions (Latorre et al., 2016). 
The secretory products can act as classic hormones reaching distant targets via 





other cytotypes of the intestinal mucosa, or directly on nerve endings close to 
the site of release. These signaling molecules, mainly peptides and hormones, 
play a key role in the control of gut secretion and mobility and in the regulation 
of food intake, postprandial glucose level and metabolism (Latorre et al., 2016). 
Along the gastrointestinal tract distinct types of EECs have been identified, 
which produce and release more than 20 peptide/hormones. Typically, EECs 
subtypes have been classified based on the primary hormone product; many 
recent studies showed the high plasticity of EECs phenotypes depending on 
their location in the intestine (Habib et al., 2012; Egerod et al., 2012; Sykaras et 
al., 2014) and thus suggested that a review of the first classification is necessary. 
Based on classical nomenclature, EECs secreting GLP-1, GLP-2 and PYY are 
referred to as L cells, whereas GIP-producing cells are classified as K cells. 
Among these gut hormones, GLP-1 and GIP have received the highest 
attention due to their insulinotropic action, and thus they gained relevance as 
therapeutic target for metabolic disorders (Zietek and Rath, 2016). EEC 
secretory products are released in response to many types of stimuli such as 
nutrients, degradation products, toxic chemicals, microorganisms and bacteria 
products (Latorre et al., 2016). In nutrient sensing, carbohydrates, lipids and 
proteins are detected via their digestion end products by a wide range of sensors 
expressed in the apical membrane of EECs (Figure 1.7). Most of the known 
EECs receptors involved in nutrient sensing are G protein-coupled receptors 
(GPCRs) (Zietek and Rath, 2016). 
The GPCR group comprises amino acid- and oligopeptide-sensing receptors, 
metabotropic glutamate receptors and taste receptors (TRs). Furthermore, 
GPCR are responsible for detection of lipid-derived long-chain/medium-chain 
fatty acids (FA) and short-chain fatty acid (SCFAs), derived after fermentation 







Figure 1.7 Nutrient sensing and stimulus-secretion coupling in intestinal endocrine cells (Zietek 
and Daniel, 2015). 
 
 
Recently intestinal nutrient transporters like the Na+ dependent glucose 
transporter (SGLT1), the Na+ dependent amino acid transporter (SLC6A19) 
(Broer and Broer, 2017; Javed et al., 2018; Cheng et al., 2017) and the H+ 
dependent di- and tripeptide transporter (PepT1) have been proposed as sensors 
in nutrient-signaling pathways suggesting a possible role as transceptors (Zietek 
and Daniel, 2015; Daniel and Zietek, 2015; Roder et al., 2014; Kuhre et al., 
2015; Diakogiannaki et al., 2013). They are integral membrane proteins that are 
expressed at apical membrane of EECs where they recognize specific substrates 
in the intestinal lumen and transport them into cells. The transport activity 





gastrointestinal peptide hormones release that thus results linked to the sensing 
of the nutrients. Specifically, the role of transceptors in the enteroendocrine 
system seems to be due to their electrogenic transport mechanism. The 
intracellular cation flow, coupled with transport of the organic substrate, causes 
membrane depolarization in the EEC that leads the opening of the voltage-
gated calcium channels. Finally, the increase of intracellular calcium level is 
followed by the exocytosis and hormone release from vesicles (Zietek and 
Daniel, 2015). 
In the intestinal lumen, glucose is the most powerful stimulus that induces the 
release of incretin hormones in vivo. Recent experimental data showed the 
involvement of the SGLT1 in glucose-mediated hormone secretion. This 
transporter is expressed in the apical membrane of L and K cells and its role as a 
transceptor is confirmed by several experiments (Roder et al., 2014; Kuhre et al., 
2015). 
Several studies suggest that the neutral amino acid transporter SLC6A19 
(B0AT1) is enriched in L cells where can act as nutrient sensor (Broer and 
Broer, 2017; Joshi et al., 2013; Norton and Murphy, 2017). Studies on mice 
lacking B0AT1 reported that the animals showed signs of protein restriction, 
protection from diet-induced obesity, improvement of glycemic control and 
increase of basal levels of GIP and GLP-1 (Javed et al., 2018; Jiang et al., 2015). 
In 2013, Diakogiannaki and colleagues reported that the intestinal transporter 
PepT1 together with Ca2+ sensitive receptor (CaSR) acts as a sensing system for 
small peptides, activating the opening of the L-type Ca2+channels with 
subsequent GLP-1 release from primary murine L-cell culture. The experiments 
showed that the secretion of GLP-1 in response to dipeptide glycine-sarcosine 
(Gly-Sar) presented the following characteristics: it was pH-dependent, with an 
increase of relative hormone release at more acidic pH; it increased with 
increments of Gly-Sar concentration; it was blocked in presence of the 





markedly reduced in primary L-cell cultures from Pept1 knockout mice 
(Diakogiannaki et al., 2013). The association between GLP-1 release and PepT1-
dependent uptake of small peptides was confirmed by studies in intestinal 
organoids prepared from mouse small intestine (Zietek et al., 2015). 
The dual role of SGLT-1, B0AT1 and PepT1 in nutrient uptake and sensing is 
thus a remarkable feature of intestinal transporters expressed in enterocytes and 
enteroendocrine cells. The role in sensing seems to be linked to the electrogenic 
nature of the transport mechanism. Non-metabolizable substrates, e.g. Gly-Sar 
for PepT1 and α-MDG (α-methyl-glucopiranoside) for SGLT-1, induce the 
GPL-1 release that thus is not dependent on the substrate per se, but on the 
cation influx generated by transporter activity (Zietek and Daniel, 2015). 
Given the insulinotropic action of some enteroendocrine hormones, the 
transceptors assume importance as a therapeutic target for metabolic disorders, 
such as diabetes and obesity (Norton and Murphy, 2017). Although the 
inhibitors of B0AT1 have the potential to be used as drugs to treat metabolic 
disorders, B0AT1 human mutations result in Hartnup disorder, suggesting that 




PepT1 pathological implications  
 
Several studies have demonstrated PepT1 involvement in pathological states 
that alter the expression level and the function of the transporter. 
Intestinal epithelial cells, constituting an interface between the gut microbiota 
and the immune system, are crucial for maintaining intestinal homeostasis. A 
failure in controlling inflammatory processes affecting intestinal epithelia cells 
level may critically contribute to intestinal inflammation. Moreover, during 





secretion of gut hormones and thus changes in feeding patterns that often 
accompanying these conditions (Zietek and Rath, 2016). 
The Inflammatory Bowel disease (IBD) is classified as a group of inflammatory 
intestinal disorders, i.e. ulcerative colitis (UC) and Crohn’s disease (CD), that are 
associated with alteration of both innate and adaptative immune system, an 
increase of luminal and mucosa-associated microbiota and an impairment of 
intestinal epithelia cells functions (Sartor, 2006). Despite the controversial 
results obtained regarding steady-state expression of PepT1 in colon (Wuensch 
et al., 2013), PepT1 expression was documented in colonic mucosa of CD and 
UD patients, at both mRNA and protein level (Merlin et al., 2001; Ziegler et al., 
2002). This evidence suggested an induction of aberrant expression of the 
transporter in the state of chronic inflammation. Although the exact molecular 
mechanism by which PepT1 expression was induced remained uncertain, the 
collective findings suggested that changes in inflammatory cytokines and 
hormone levels during disease (Chouliaras et al., 2013; Valentini et al., 2009) 
affected the transporter expression and function. For example, in Caco-2 BBE 
cells, an epithelial cell line derived from human colon adenocarcinoma, the 
administration of proinflammatory cytokines TNF-α and IFN-γ was associated 
with an increase of PepT1 expression at protein level and resulting in an 
increase in transport activity (Buyse et al., 2003; Foster et al., 2009; Vavricka et 
al., 2006).  Among the adipocyte-secreted hormones, leptin was detected in 
colonic epithelial cells from inflamed tissues (Sitaraman et al., 2004) and was 
shown also to increase PepT1 expression in Caco-2 BBE cells (Nduati et al., 
2007). 
Concomitantly with the expression of colonic PepT1, many studies reported the 
ability of PepT1 to transport a wide range of small peptides produced by 
bacterial intestinal flora, suggesting an involvement of the transporter in 





For instance, PepT1 mediated transport of formyl-methionyl-leucyl-
phenylalanine (fMLP) a bacterial chemiotactic oligopeptides (Merlin et al., 2001), 
muramyl dipeptide (MDP) a constituent of bacterial cell wall (Vavricka et al., 
2004) and L-Ala-γ-D-Glu-meso-DAP (Tri-DAP) a peptide-glycan degradation 
product from bacteria (Dalmasso et al., 2010). Moreover, PepT1-mediated 
uptake of bacterial peptides could trigger the activation of inflammatory 
signaling pathways in colonic epithelial cells that exacerbated the disease state 
initiating a proinflammatory response. PepT1-mediated transport of fMLP 
potentially stimulated expression of MHC-1 (Merlin et al., 2001); MDP activated 
nuclear factor kappa B (NF-kB) and chemokine production (Vavricka et al., 
2004). Additionally, Tri-DAP mediated the activation of the mitogen activated 
protein kinase (MAPK) pathway and upregulation of IL-8 (Dalmasso et al., 
2010). 
PepT1 was expressed also in macrophages, which might be recruited during 
intestinal inflammation (Ayyadurai et al., 2013). In macrophages, the PepT1-
mediated uptake of bacterial products might modulate the secretion of 
proinflammatory cytokines that, together with the increased cytokine level in 
enterocytes, contribute to the pathogenesis of the intestinal inflammation 
(Spanier and Rohm, 2018).  
Interestingly, the first study on the relationship between IL-16 and PepT1 in the 
pathogenesis of IBD was conducted on pufferfish (Tetraodon nigroviridis), a teleost 
fish model (Wang et al., 2013). The results provided both in vivo and in vitro 
evidence that IL-16 was able to trigger PepT1 expression, increasing the 
transporter-mediated uptake of fMLF, that thereby led to severe colon 
inflammation. The use of a fish model of IBD, as complementary to mammalian 
models, showed to produce great benefits providing new insights into the 
molecular mechanism underlying IBD development. Better understanding of 
the IL-16 biology from fish to mammals should aid the development of IL-16 





To date there is no known pathology associated with the malfunction of the 
PepT1 oligopeptide transporter. Despite this, two single nucleotide 
polymorphisms (SNPs) found in ethnically diverse cohorts, were associated with 
altered PepT1 activity. Specifically, the exchange of phenylalanine to tyrosine in 
position 28 (Phe28Tyr) reduced transporter-to-substrate affinity but did not 
influence transporter expression (Anderle et al., 2006); the exchange of proline 
to leucine in 586 position (Pro586Leu) impaired transport capacity and 
decreased PepT1 protein expression (Zhang et al., 2004b). In the context of 
identifying human PepT1 polymorphisms for associations with IBD, Zucchelli 
and colleagues analyzed two cohorts of Swedish and Finnish IBD patients. They 
discovered one functional PepT1 SNP, namely rs2297322, that was associated 
with CD in both cohorts. Interestingly, the SNP showed an opposite effect: in 
Swedish cohorts it was associated with increased risk of CD, while in Finnish 
cohorts it was shown to be protective against the disease state (Zucchelli et al., 
2009). Notably, a recent study failed to identify an association between the 
rs2297322 and IBD susceptibility in a German cohort, suggesting that the role 
of this SNP in disease still remains unclear (Wuensch et al., 2014). 
PepT1 expression was shown to be altered in some carcinomas such as 
pancreatic carcinoma, prostate cancer, hepatocellular carcinoma, gastric cancer 
and colorectal cancer (Landowski et al., 2005; Tai et al., 2013; Gong et al., 2017; 
Viennois et al., 2016). In patients with IBD, the long-term exposure to chronic 
inflammation was the primary risk factor for colorectal cancer, also referred to 
as colitis-associated cancer (CAC). In a recent study, Viennois and coworkers 
reported a role of PepT1 in promoting CAC. Compared to wild-type animals, a 
significantly increase in tumor growth and size was reported in mice 
overexpressing human PepT1; the opposite effect was observed in Pept1 
knockout mice (Viennois et al., 2016). 
Moreover, several studies suggested an alteration of PepT1 expression and 





resistance is one of the patophysiological factors in the development of obesity, 
which is mainly due to impaired leptin receptor signaling. Hindlet and 
coworkers reported that, although the acute leptin treatment enhanced the 
absorption of di- and tripeptides via PepT1 transporter (Hindlet et al., 2007), 
PepT1 levels and activity were downregulated in hyperleptinemic states of leptin 
resistance (Hindlet et al., 2009). Thus, the intestinal PepT1 activity may be 
impaired by leptin resistance in obesity, possibly affecting the PepT1 mediated 
uptake of peptides known to induce satiety (Spanier and Rohm, 2018). 
PepT1 expression and activity was also affected by insulin level and diabetes. 
Studies in Caco-2 cells treated with insulin, showed an increase of PepT1 
protein in apical membrane (Thamotharan et al., 1999). The PepT1 activity was 
investigated in kinetic analysis in BBMVs prepared from jejunum of diabetic 
rats. Transport data showed unaltered transporter affinity but an increase of 
transporter maximal rate, which was probably due to an increase of number of 
transporters expressed on cellular membrane (Gangopadhyay et al., 2002). 
Interestingly, some antidiabetic drugs were known to inhibit the transporter in 
noncompetitive manner, such as Glibenclamide and Nateglinide (Sawada et al., 
1999; Terada et al., 2000). 
 
 
PepT1 therapeutic applications 
 
The wide range of substrate specificity is a remarkable feature of the SLC15 
family. This suggests the possibility to develop peptide-based prodrugs that 
target intestinal transport to improve oral drug delivery. Although structural 
basis of PepT1 substrate promiscuity remains largely unknown, the crystal 
structures from several PepT1 homologues reveals conserved features and 
provide a template for prodrug development. 
Recently, Minhas and colleagues used previous dipeptide-bound crystal 





prodrug-bound crystal structure of PepT1 from the bacterium Staphylococcus 
hominis, PepTSh. Based on the experimental results, the authors proposed a 
structure-based pharmacophore model for valacyclovir binding to peptide 
transporters, suggesting a novel route for prodrug scaffold design (Minhas and 
Newstead, 2019). Interestingly, three different template structures of bacterial 
POT transporters were used to construct multiple structural models of human 
PepT1 that represent different conformational states of the transporter during 
transport and inhibition phases. Based on the features of binding site of human 
PepT1 models, computational methods allowed to identify also several 
compounds that bind to them. Finally, the selected substrates were tested with 
uptake kinetics measurements and electrophysiological assays revealing one new 
substrate and four novel inhibitors of human PepT1 (Colas et al., 2017). 
Studies performed in 1970s and 1980s reported that intestinal peptide 
transporters can also recognize and even transport compounds bearing sterical 
resemblance to the backbone of di- and tripeptides (Brandsch et al., 2008). 
Classical and well-characterized drug substrates of PepT1 are the numerous 
amino β-lactam antibiotics such as many belonging to the penicillin and 
cephalosporin classes (Ganapathy et al., 1995; Bretschneider et al., 1999); 
selected angiotensin-converting enzyme (ACE) inhibitors such as captopril and 
ACE inhibitor ester prodrugs such as enalapril and fosinopril (Zhu et al., 2000; 
Shu et al., 2001). Others well-known PepT1-compatible drugs include bestatin 
(Inui et al., 1992), alafosfalin (Brandsch et al., 2008) and amino acid-conjugated 
antiviral drugs such as valacyclovir, an ester prodrug used as oral treatment of 
viral infection (Balimane et al., 1998). PepT1 is able to recognize also substrates 
that do not present a classical peptide bond, such as 4-aminophenylacetic acid, 
ω-amino fatty acids (Doring et al., 1998) and δ-amino levulinic acid (ALA) a 
precursor of cellular porphyrin synthesis which is used as a photodynamic agent 





The broad substrate specificity, the high transport rate and the intestinal 
expression make PepT1 a good target for efficient oral delivery of poorly 
bioavailable drugs. It is worth to mention that one of the leading causes of 
compound failure in preclinical and clinical drug development resides in its poor 
oral bioavailability. So, a possible approach is to increase drug oral availability 
developing prodrugs that target intestinal transporters. For example, the 
interactions in gut epithelium between ACE inhibitor prodrugs and PepT1 
provide an oral availability of the drugs in a dose generally between 40% and 
90% (Zhu et al., 2000; Shu et al., 2001). 
Moreover, PepT1 has been shown to increase the bioavailability of molecules 
attached to amino acids or di- and tripeptides becoming an attractive target for 
potential therapeutic models for developing and enhancing drug-delivery 
systems. 
Recently, target therapy has become a potent therapeutic strategy for tumor. 
Particularly, the delivering of antitumor drugs into specific locations of a tumor 
provides the advantage of limiting toxicity in healthy tissues. In this context, the 
attention on some antitumor target such as nanoparticle, tumor specific antigen, 
tumor specific receptor has increased even more. For example, Gong and 
coworkers explored the feasibility of targeting PepT1 to improve the antitumor 
efficacy of Doxorubicin in human hepatocellular carcinoma therapy using a 
Doxorubicin-tripeptide conjugate (Gong et al., 2017). Indeed, in vivo and in vitro 
experiments proved that Doxorubicin-tripeptide conjugates can be transported 
into liver cancer cells by PepT1 playing an anti-tumor action. Moreover, the 
anti-cancer treatment by Doxorubicin-tripeptide conjugates showed a greater 
efficacy and a lower toxicity than that of Doxorubicin (Gong et al., 2017). 
Moreover, with the rapid nanotechnology advances, nanoparticulate drug 
delivery systems (nano-DDS) show great progress in drug delivery and represent 





bioavailability. Among the various delivery strategies in the field of nano-DDS, 
transporter-targeted prodrug strategies have been widely investigated. 
PepT1 transporter has been investigated to assess the ability to uptake dipeptide 
modified nanoparticles. Although few studies have been conducted up to now, 
the results are promising and show that PepT1 could work as a desirable 
mediator of oral nanoparticulate drug delivery (Du et al., 2018; Gourdon et al., 
2017; Gourdon et al., 2018; Kou et al., 2018). 
 
In this thesis work it is reported the functional characterization of the newly 
cloned PepT1a-type proteins from intestine of zebrafish and Atlantic salmon, 
which completes the functional picture of the PepT type transporters expressed 





























The full-length cDNA encoding zebrafish PepT1a (submission: 
BankIt2285160 zfPepT1a GenBank MN723161; date release: June 21, 2020) and 
the open reading frame (from start ATG to stop codon) encoding Atlantic 
salmon PepT1a (GenBank Acc. No. XM_014172951.1) and PepT1b (GenBank 
Acc. No. NM_0011466882.1) were subcloned in pSPORT1 for expression in X. 
laevis oocyte. All constructs were verified by sequencing.  
To improve the expression of Atlantic salmon PepT1a and PepT1b in the 
membrane of X. laevis oocytes, a 3’UTR sequence from rat Divalent metal 
transporter 1 (rDmt1, alias rat slc11a2; GenBank Acc. No. NM_013173.2) was 
added to the end of the Atlantic salmon PepT1a and PepT1b coding sequences 
(CDS), as previously reported for Dictyostelium discoideum natural resistance-
associated macrophage protein 1 (Nramp1) and 2 (Nramp2) (Buracco et al., 
2015). The 1725 bp sequence added contains two poly-adenylation signals and a 
poly(A) tail at the 3’end.  
 
 
Plasmid amplification, extraction and purification 
 
The recombinant plasmids (pSPORT1-zfPepT1a, pSPORT1-asPepT1a and 
pSPORT1-asPepT1b) were introduced into JM109 strain of E. Coli after heat-
shock procedure. First, cells were incubated with DNA on ice for 20 minutes; 





they were put back on ice for 2 minutes. Transformed bacteria were then left to 
grow in agitation at 37°C for about 1 hour in Luria-Bertani medium (LB), 
centrifuged (4000 g for 10 minutes) and plated on Petri plates containing 
selective medium (LB-Agar added with ampicillin 50 mg/mL) and incubated at 
37°C. After 24 hours, single colonies were picked up and inoculated in liquid 
selective medium (LB added with ampicillin 50 mg/mL) and incubated at 37°C 
over night with shaking. The plasmid DNAs were extracted using Wizard® Plus 
SV Miniprep (Promega Italia, Milan, Italy) following supplier instructions and 
eluted in 50 µl of nuclease free water. 
 
 
In vitro transcription 
 
In order to achieve an efficient in vitro transcription, the recombinant plasmid 
(pSPORT1-zfPepT1a, pSPORT1-asPepT1a and pSPORT1-asPepT1b) was 
linearized in 3’ direction with respect to the coding region with NotI (Promega 
Italia), purified with Wizard SV Gel and PCR clean-up system (Promega Italia) 
and eluted in 40 µl of nuclease free water.  
The linearized DNA was incubated at 37°C for 3 hours in presence of 200 units 
of T7 RNA polymerase (Promega Italia). The in vitro transcription reaction was 
composed as follow: 18 μl of Transcription Buffer 5X, 8 μl of DTT 100 
mmol/L, 2 μL of RNasin® Ribonuclease Inhibitors 40 U/μL, 13 μL rNTPs 
mix (rATP, rCTP, rUTP 5 mmol/L and rGTP 0.5 mmol/L), 6.5 μL of Cap 
Analog 10 mmol/L, 10 μl T7 RNA polymerase 20 U/μL (final volume 90 μL). 
After 10, 20, and 40 minutes from the beginning of the incubation, 1 μL of 
rGTP 25 mmol/L was added to the reaction. After 1 hour from the start of the 
transcription, a mix of 4 μl of Trascription Buffer 5X, 1 μl of DTT 100 
mmol/L, 1 μL of RNasin® Ribonuclease Inhibitors 40 U/μL, 5 μL of rNTPs 





nuclease-free water, was added to the sample. At the end of 3 hours, the 
reaction was stopped by adding 101 μL of nuclease-free and 150 μL of LiCl 8 
mol/L and stored at -80 °C over night. All reagents and enzymes were supplied 
by Promega Italia. The transcribed cRNA was precipitated and washed with 
EtOH 70%. The purified cRNA was then resuspended in a small volume of 
nuclease-free water, visualized by denaturing formaldehyde-agarose gel 
electrophoresis and quantified by NanoDropTM 2000 Spectrophotometer 
(Thermo Fisher Scientific). 
 
 
Heterologous expression in Xenopus laevis oocytes 
 
X. laevis oocytes result to be very useful expression systems for carrying out 
experimentations. They grant a high expression rate of exogenous proteins 
(even after only 18 hours) with high density of proteins produced after 
cytoplasmic injection of mRNA. Their efficient biosynthetic apparatus allows to 
reproduce the post-translational modifications needed for the correct targeting 
and the functionality of the proteins. Moreover, X. laevis oocytes allow the co-
expression of many proteins just requiring co-injections of the corresponding 
mRNAs. In X. laevis oocytes the endogenous membrane proteins have low 
expression levels, furthermore the endogenous channels have been studied 
extensively, thus it is an easy task to distinguish between exogenous and 
endogenous proteins. X. laevis oocytes can survive in culture for long periods of 
about ten days, without requiring particular sterile conditions. Their dimensions 
suit well for microinjections and for applying the voltage clamp technique. 
Despite the above-mentioned advantages, X. laevis oocytes, have also some 
disadvantages. Unfortunately, the expression of exogenous proteins is just 
transient in X. laevis oocytes and even if their cells are in quiescent state, the 





it is worth to mention that the ideal temperature for maintain X. laevis oocytes is 
about 18°C and it is significantly lower than the one needed for many 
exogenous proteins, so the folding process can suffer from this difference. 
All the employed oocytes were prepared following the procedures described 
(Bossi et al., 2007) and they were collected from adult females of X. laevis 
(Envigo, San Pietro al Natisone, Italy). The frogs were anaesthetised by 
immersion in a solution of 0.10% (w/v) of tricaine methansulfonate (MS222) in 
tap water adjusted at final pH 7.5 with sodium bicarbonate. After the treatment 
with an antiseptic agent (Providone-iodine 10%), the frog abdomen was incised, 
and the portions of the ovary were removed. Then, the oocytes were treated 
with 1 mg/mL of collagenase (Sigma collagenase Type IA from Clostridium 
histolyticum) in Ca+ free solution, ND96 (NaCl 96 mmol/L, KCl 2 mmol/L, 
MgCl2 1 mmol/L, CaCl2 1.8 mmol/L, HEPES 5 mmol/L, pH 7.6), for a period 
of at least 1 hour at 18°C. The healthy and full-grown oocytes were selected and 
separated manually in NDE solution (ND96 plus pyruvate 2.5 mmol/L and 
gentamycin sulphate 0.05 mg/mL). After 24 hours at 18 °C, the oocytes were 
injected with 25 ng (in 50 nL of water) of in vitro synthesised PepT1 cRNA using 
a manual microinjection system (Drummond Scientific Company, Broomall, 
PA, USA). Before electrophysiological studies the oocytes were then incubated 
at 18 °C for 3-4 days in NDE. All the experiments and the surgical operations 
were conducted using experimental protocol approved locally by the Committee 
of the “Organismo Preposto al Benessere degli Animali” of the University of Insubria 










Electrophysiology and data analysis 
 
The use of electrophysiology results very helpful in studies on membrane 
transporters. By recurring to this technique, it is possible to control the cell 
membrane voltage and to hold it during the experiments. Moreover, the results 
may be obtained immediately, so the data can be analysed and interpreted 
almost in real-time. This feature allows to modify or to adjust the protocols 
employed if needed, while the experimental session is ongoing. Therefore, it 
results clear that this technique greatly reduces the downtime and increases the 
efficiency of each experiment.  During the transport cycle, electrogenic 
transporters translocate the electric charges and they are affected greatly by the 
transmembrane potential. As a consequence, when the membrane voltage as 
well as the electrical gradient are uncertain, the experimental results on the 
transporter activity are not very accurate. Using the so called voltage-clamp 
technique, it is possible to hold the membrane potential to a desired value, thus 
the measured currents can be considered caused only by the transporter activity. 
 
 
Two Electrode Voltage Clamp (TEVC) 
 
During the first ‘40s, Marmont and Cole presented the voltage-clamp technique 
(Cole and Curtis, 1941). Shortly after, Hodgkin, Huxley and Katz used it for 
investigating the ionic currents underlying the action potential in nerve axons 
(Hodgkin et al., 1952). As soon as the first transporter was cloned and expressed 
in X. laevis oocytes, the voltage-clamp technique, particularly the Two Electrode 
Voltage Clamp (TEVC) technique has started to be employed extensively for 
studying membrane transporters (Hediger et al., 1987; Ikeda et al., 1989; Parent 
et al., 1992; Mager et al., 1993). 
In TEVC, two microelectrodes are used, one is responsible for recording the 





a feedback system, the measured voltage is compared to the holding potential; if 
needed a feedback current is injected into the cell so the desired voltage is held. 
Therefore, the membrane voltage is the independent variable and it is 
controlled, the dependent variable is the membrane current and it is measured. 
When the ion-coupled transporters are located in the membrane, the 
transmembrane current take place due to the transport activity causing 
membrane voltage changes, thus the current injected to compensate this 
variation can be recorded and it is an indication of the activity of transporters. 
The TEVC circuit (Figure 2.1) consists of two operational amplifiers, one to 
stabilize the measured membrane potential via the voltage follower and one to 
perform voltage clamp by negative feedback amplifier; an ammeter to measure 
the current flow (IM); two resistances, one of the potential measuring (RPE) and 
the other of the current supplying electrode (RCE); a model membrane is 
represented as a parallel circuit of a resistor (RM) and a capacitor (CM) (Bierwirtz 
and Schwarz, 2014). 
 
Figure 2.1 Two electrode voltage-clamp circuit. The schematic drawing of a voltage follower 
(operational amplifier with unity gain) in A, and an operational amplifier that acts as a negative 
feedback amplifier in B. VVC is the voltage command that is to be clamped to the membrane. IM 





current electrode resistance, respectively. CM is the membrane capacitance and RM is the 
membrane resistance (Bierwirtz and Schwarz, 2014). 
 
 
TEVC experimental setup, protocols and data analysis 
 
The membrane currents under voltage clamp conditions, controlled by Clampex 
10.2 (Molecular Devices, Sunnyvale, CA, USA), were recorded by TEVC 
(Oocyte Clamp OC-725C, Warner Instruments, Hamden, CT, USA) that was 
connected to a computer through an AD/DA (analog-digital, digital-analog) 
converter (DIgiData 1440A, Axon Instr.). A stereoscope (Wild M3B, Leica 
Microsystems AG, Wetzlar, Germany) was used to visualize and to place the 
oocytes in the recording chamber connected to perfusion system. The solution 
in the chamber was aspired by a vacuum pump through a suction reservoir 
connected to the oocyte well. In the recording chamber, the oocytes were 
impaled with two Ag/AgCl electrodes positioned on the electrode holders that 
were moved using micromanipulators (MM-33, Märtzhäuser Wetzlar GmbH & 
Co. KG, Wetzlar-Steindorf, Germany). The intracellular glass microelectrodes, 
with a tip resistance of 0.5-4 MΩ, were filled with KCl 3 mol/L. Bath electrodes 
were connected to the experimental oocyte chamber via agar bridges (3% agar in 
KCl3 mol/L). All the equipments needed for the recording are placed inside a 
Faraday cage. The cage and all the instruments inside of it were grounded. 
The holding potential was kept at -60 mV; the voltage pulse protocol consisted 
of 10 square pulses from -140 to +20 mV (20 mV increment) of 700 ms each. 
Signals were filtered at 0.1 kHz or 0.5 kHz before sampling at 2 kHz or 1 kHz, 
respectively. Transport-associated currents were calculated by subtracting the 
traces in the absence of substrate from those in its presence. 
To study the pre steady-state (PSS) currents elicited by voltage jumps in absence 
of organic substrate, the isolation method consisted of a double-exponential 





method allows to separate the transporter mediated transients (or PSS currents) 
from the total current across the oocyte membrane by subtraction of the fast 
capacitive and steady state components. The total current to the time course of 
the “on” response was fitted with double-exponential function [2.1]: 
                                               𝐼𝑡 = 𝐼𝑚 𝑒(− 𝑡𝜏𝑚) +  𝐼𝑃𝑆𝑆 𝑒(− 𝑡𝜏𝑃𝑆𝑆) +  𝐼𝑆𝑆                [2.1] 
 
 
where It is the total current across the oocyte membrane; t is the time; Im is the 
initial value of the membrane capacitive current, which has a time constant of 
decay m; IPSS is the initial transporter PSS current, which has a time constant of 
decay PSS ; and ISS is the steady state current (Sala-Rabanal et al., 2006). 
The fast component of transient currents has time constant (m) of about 1 ms 
that is potential-independent and it represents the charging of membrane 
capacitance, whereas the slow one has a  time constant (PSS) on average of tens 
of milliseconds and that is potential-dependent, strictly related to the presence 
of transporters on the plasma membrane. 
 To determine the time constant value at the holding potential of -60 mV, the 
currents at the "off" response at all tested potentials, were fitted with double 
exponential and the obtained values of  𝑃𝑆𝑆𝑜𝑓𝑓  were averaged. At each voltage, 
the amount of displaced charge (Q) was calculated by integrating the isolated 
traces after zeroing any residual steady-state transport current. Data was 
analyzed using Clampfit 10.7 (Molecular Devices). 
For statistical analysis, descriptive statistic, fitting and figure preparation, Origin 
8.0 (OriginLab, Northampton, MA, USA) was used.  Number of samples and 
batch were reported in each figure. The analysis of the statistical significance 





was done using one-way ANOVA followed by Bonferroni’s post-hoc multiple 





The external control solution had the following composition: NaCl (or TMA) 98 
mmol/L, MgCl2 1 mmol/L, CaCl2 1.8 mmol/L. For pH 6.5 the buffer solution 
Pipes 5 mmol/L was used; Hepes 5 mmol/L was used to obtain a pH 7.6 and 
pH 8.5. The final pH values were adjusted with HCl or NaOH. The substrate 
oligopeptides tested were: glycine-glutamine (Gly-Gln), alanine-alanine (Ala-
Ala), glycine-glycine-glycine (Gly-Gly-Gly), glycine-sarcosine (Gly-Sar), glycine-
aspartate (Gly-Asp), aspartate-glycine (Asp-Gly) (Sigma-Aldrich, Milan, Italy); 
lysine-glycine (Lys-Gly) (Bachem, Bubendorf, Switzerland); glycine-lysine (Gly-
Lys), methionine-lysine (Met-Lys), lysine-methionine (Lys-Met) (Genicbio, 
Shangai, China, www.genicbio.com). Every oligopeptide was added at the 
indicated concentrations (from 0.01 to 30 mmol/L) in the NaCl or TMA buffer 















Chapter 3. Results 
 
 
With the increase in availability of genome sequences of several teleosts in 
databanks, it progressively became evident that teleost PepT1-type proteins 
were the result of a gene duplication, and the presence of PepT1a form of 
SLC15A1 (SLC15A1a) protein was confirmed in many fish species (Verri et al., 
2017), but to date it is still not known if PepT1a-type proteins are functional. To 
the best of the author knowledge, in this work the data about PepT1a function 





Zebrafish pept1a (slc15a1a) cDNA is 2478 bp long, with a coding sequence 
(CDS) of 2154 bp encoding a protein of 717 amino acids. The complete CDS of 
Atlantic salmon pept1a (slc15a1a) of 2157 bp encodes for a protein of 718 amino 
acids. PepT1a (Slc15a1a) vs. PepT1b (Slc15a1b) amino acid sequences share 78% 
similarity and 62% identity in zebrafish and shared 77% similarity and 64% 
identity in Atlantic salmon (see supplementary material, Figure S.1 for zebrafish 
proteins and Figure S.2 for Atlantic salmon proteins). Hydropathy analysis 
predict 12 potential transmembrane domains for both PepT1a proteins with a 
large extracellular loop between transmembrane domains IX and X. Important 
motifs such as the PTR2 family proton/oligopeptide symporter signatures are 
present in zebrafish PepT1a sequence as well as in Atlantic salmon PepT1a. The 
predicted membrane topology of zebrafish PepT1a and Atlantic salmon PepT1a 







Figure 3.1 Predicted membrane topology of zebrafish PepT1a (zfPepT1a). In the amino acid 
sequence, putative transmembrane domains, obtained using the TMHMM v. 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) program as implemented in SMART (Letunic et 
al., 2015), are indicated and named I to XII. Predicted conserved PTR2 family 
proton/oligopeptide symporters signatures were obtained using the ScanProsite tool 
(https://prosite.expasy.org/scanprosite/) (Hulo et al., 2006): PTR2_1 motif 1 - PROSITE 
pattern PS01022 - amino acid residues 80-104 (in green); and PTR_2 motif 2 - PROSITE 
pattern PS01023 - amino acid residues 173-185 (in purple). Potential extracellular N-
glycosylation sites (blue), potential cAMP/cGMP-dependent protein kinase phosphorylation 
sites at the cytoplasmic surface (in orange) and potential protein kinase C phosphorylation sites 
at the cytoplasmic surface (in yellow) were obtained using the ScanProsite tool. The picture was 
















Figure 3.2 Predicted membrane topology of Atlantic salmon PepT1a (asPepT1a). In the amino 
acid sequence, putative transmembrane domains, obtained using the TMHMM server v. 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/), are indicated and named I to XII. The predicted 
conserved PTR2 family proton/oligopeptide symporters signatures were obtained using the 
ScanProsite tool (https://prosite.expasy.org/scanprosite/)(Hulo et al., 2006): PTR2_1 motif 1 - 
PROSITE pattern PS01022 - amino acid residues 76-100 (in green); and PTR2_2 motif 2 - 
PROSITE pattern PS01023 - amino acid residues 169-181 (in purple). Potential extracellular N-
glycosylation sites (blue) were obtained using NetNGlyc 1.0 server 
(http://www.cbs.dtu.dk/services/NetNGlyc/).Potential cAMP/cGMP-dependent protein 
kinase phosphorylation sites at the cytoplasmic surface (in orange) and potential protein kinase 
C phosphorylation sites at the cytoplasmic surface (in yellow), were obtained using the 
ScanProsite tool (Hulo et al., 2006). The picture was obtained using Protter - visualize 

















Several ion-coupled transporters show distinctive kinds of current, which are 
believed to represent the operating modes of these proteins. The transport 
associated currents are steady state currents elicited in the presence of the 
substrates. These currents are due to the translocation through the cell 
membrane of substrates together with the co-transported ions. The transient 
currents, or pre steady-state currents, are typically caused by voltage or ion 
concentration changes. These are capacitive currents arising from the confined 
movement of charges within the membrane electrical field. The moved charges 
can be either the driving ions that interact with protein residues and/or the 
intrinsic charged amino acids of the transporter. Transport currents and 
transient currents are mutually exclusive; while the former are visible in the 
presence of substrate and increase till reaching saturating concentration, the 
latter are clearly observable in absence of substrate and disappear completely 
when saturating amount of substrate is present. Both the above-mentioned 
currents are present in X. laevis oocytes overexpressing of PepT1 and they can 
be measured by Two Electrode Voltage Clamp (TEVC) technique. The 
biophysical analysis of the transport currents and of the pre steady-state currents 





Seventy-two hours after injection of 25 ng of cRNA encoding zebrafish and 
Atlantic salmon PepT1a and PepT1b, oocytes were tested through TEVC 
technique for evaluating the transporter function. Inward transport currents 
were recorded in voltage clamp at the holding potential of -60 mV in the 
presence of 1 mmol/L of Gly-Gln, Ala-Ala and Gly-Gly-Gly in sodium solution 





gut condition). The representative current traces, reported in Figure 3.3, show 
that the newly cloned zebrafish and Atlantic salmon PepT1a are electrogenic 
transporters, as well as their PepT1b counterparts. The inward currents elicited 




Figure 3.3 The representative traces of transport currents in zebrafish (zfPepT1a and 
zfPepT1b) and Atlantic salmon (asPepT1a and asPepT1b) transporters heterologously expressed 
in Xenopus laevis oocytes. For all cases, the currents were recorded at the holding potential (Vh) of 
-60 mV and for pH  values of 6.5 and 7.6, in the presence of (1 mmol/L) Gly-Gln (GQ), Ala-
Ala (AA) and Gly-Gly-Gly (GGG) substrates indicated by the bars above. For zebrafish 
transporters only, the currents were measured also at pH 8.5. 
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To evaluate the effect of sodium on the transport activity of both PepT1a 
transporters, the currents elicited by 3 mmol/L of Gly-Gln were compared in 
two different buffer solutions. The first contained sodium, whereas in the 
second the sodium was substituted by tetramethylammonium (TEA). During 
these experiments, the currents were evaluated in a membrane potential range 
from -140 mV to + 20 mV at pH 7.6.   
 No differences in current amplitudes and in the shape of I/V relationship are 
highlighted confirming that zebrafish PepT1a and Atlantic salmon PepT1a are 




Figure 3.4 Current-voltage relationships of transport-associated currents in zebrafish PepT1a 
(zfPepT1a, right) and Atlantic salmon PepT1a (asPepT1a, left), in the presence of 3 mmol/L 
Gly-Gln in sodium (Na) saline buffer (square) and tetramethylammonium (TMA) saline buffer 
(empty circle) at pH 7.6. The values are the mean ± SEM of 5 up to 12 oocytes belonging to 
one or two batches, in each case. The transport-associated currents were obtained by subtracting 
the currents recorded in absence of the substrate to those in its presence. 
 
 
The pH dependence of the transport activity of zebrafish and Atlantic salmon 
PepT1a and PepT1b transporters was investigated and statistically compared. 
The transport associated currents were recorded under the same experimental 

































conditions previously described and shown in Figure 3.3, the currents reported 
in the histogram were obtained by subtracting the currents recorded in absence 
of the substrate to those in its presence. These currents were collected from 4 to 
7 oocytes belonging to at least 2 different batches and their amplitudes were 
averaged. In the same experiment the mammalian PepT1 transporter of rabbit 
(GenBank Acc. No. U13707.1) (Boll et al., 1994) was tested as well. The results 
are shown in the histograms in Figure 3.5.  
The transport current amplitudes, elicited in oocytes expressing the tested 
proteins, show different profiles and pH dependences.  
In zebrafish PepT1a the transport associated currents, in the presence of Gly-
Gln and Ala-Ala dipeptides, decrease with the increase of the pH from 6.5 to 
8.5, with significant differences in current amplitudes between these two pH 
conditions (p<0.01 for Gly-Gln and p<0.05 for Ala-Ala).   
Under the same experimental conditions, zebrafish PepT1b shows higher 
currents at pH 7.6 with respect to the ones obtained for the other two pH 
conditions (pH 6.5, pH 8.5). In zebrafish PepT1b, the differences in current 
amplitudes in the presence of dipeptides are statistically different between pH 
7.6 and pH 8.5 (p<0.001 for Gly-Gln and p<0.01 for Ala-Ala) and between pH 








Figure 3.5 The means of the transport-associated currents at different pH conditions, at pH 
6.5, 7.6 and 8.5 for zebrafish transporters (zfPepT1a and zf PepT1b); at pH 6.5 and 7.6 for 
rabbit (rbPepT1) and Atlantic salmon (asPepT1a and asPepT1b) transporters. The transport 
currents elicited by Gly-Gln (top left), Ala-Ala (top right) and Gly-Gly-Gly (bottom) (1 
mmol/L) at -60 mV at pH 6.5 (green), 7.6 (blue) and 8.5 (orange) are reported as mean ± SEM 




For zebrafish PepT1a and PepT1b the current amplitudes elicited by Gly-Gln 
and Ala-Ala did not differ statistically between pH 7.6 and 6.5. Although 
zebrafish transporters work well with neutral substrates, PepT1a shows higher 
currents of the presence of Ala-Ala, while PepT1b exhibits similar current 
amplitudes for both dipeptides at the three pH conditions tested.  
In Atlantic salmon PepT1b, only a slight increase in the currents is observed in 
the presence of Gly-Gln and Ala-Ala when decreasing the pH from 7.6 to 6.5; in 























































































































in amplitudes if compared to the values at pH 7.6 (p<0.001) for all the tested 
substrates.  
When the substrate is the tripeptide Gly-Gly-Gly, the transport associated 
currents are drastically reduced to few nanoamperes regardless of the pH 
conditions in zebrafish PepT1a. At pH 6.5, the same tripeptide elicits currents 
of few tens of nA in Atlantic salmon PepT1a that significantly decrease at pH 
7.6 (p<0.01). In contrast to the peculiar alkaline pH preference of zebrafish 
PepT1b, reducing the external pH from 7.6 to 6.5 significantly increases 
(p<0.05) the current amplitudes in the presence of Gly-Gly-Gly. The same 
effect is observed in Atlantic salmon PepT1b but not for rabbit PepT1 
confirming that also in the presence of the tripeptide, the pH effect on transport 
associated currents is not statistically detectable for the mammalian transporter. 
To define the voltage dependence and apparent substrate affinity of zebrafish 
and Atlantic salmon PepT1a, the transport currents for Gly-Gln from 0.01 to 30 
mmol/L, were recorded at two pH values (7.6 and 6.5), in the range of voltage 






Figure 3.6 Current vs. Voltage (I/V) relationships for zebrafish PepT1a (top) and Atlantic 
salmon PepT1a (bottom) were obtained by subtracting the current traces in the absence of the 
substrate to that in the presence of Gly-Gln from 0.01 to 10 mmol/L at pH 6.5 and to 30 
mmol/L at 7.6. Data are reported as mean ± SEM of 9 up to 14 oocytes from 3 batches. The 
transport-associated currents were obtained by subtracting the current recorded in absence of 
the substrate to those in its presence. 
 
 
The data of the transport associated currents, collected at pH 6.5, show that for 
zfPepT1a the Gly-Gln 3 mmol/L is the saturating value; in fact, a further 
increment of the concentration to 10 mmol/L in fact does not increase the 
current amplitude, independently from the tested voltages. For Atlantic salmon 
PepT1a transporter the I/V curves recorded in the presence of Gly-Gln 
concentrations from 1 to 10 mmol/L largely overlap suggesting that at pH 6.5 
the saturating values is reached at 1 mmol/L of Gly-Gln. The I/V plot at pH 
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7.6 shows that the transport associated currents in the zebrafish transporter 
constantly increase with the substrate concentration and do not reach the 
maximal value even in the presence of 30 mmol/L of Gly-Gln. At pH 7.6 in the 
Atlantic salmon transporter the saturating concentration is reached around 10 
mmol/L of the substrate. The I/V relationship at the two pH values for both 
transporters was fitted with the Michaelis-Menten equation to determine the 
kinetic parameters: the maximal relative current (Imax), the apparent substrate 
affinity (i.e. the apparent concentration of peptide that yields one-half of Imax; 
K0.5) and the transport efficiency (Imax/K0.5) (Figure 3.7). 
 
 
Figure 3.7. Dose response analysis: K0.5, Imax and transport efficiency of zebrafish (A, B, C) and 
Atlantic salmon (D, E, F) PepT1a (Slc15a1a) evaluated in the presence of Gly-Gln. The current 
values (Figure 3.6) were subsequently fitted with the Michaelis-Menten equation [𝐼0 =−𝐼𝑚𝑎𝑥1+([𝑆] 𝐾0.5 ⁄ ) + 𝐼𝑚𝑎𝑥] to obtain K0.5, i.e. the substrate concentration that elicits half of the 
maximal current (Imax), at each indicated voltage and at pH 6.5 (green square) and 7.6 (blue 















































































































































circle): A and D, the inserts (Aa and Dd) are enlargements of K0.5 at pH 6.5. The relative 
maximal current (Imax) at each voltage and pH is plotted in B and E. In C and F, the transport 




As Figure 3.7 shows in A and D, zebrafish and Atlantic salmon PepT1a affinity 
(1/K0.5) for Gly-Gln increases with the decrease of pH, and at pH 6.5 affinity is 
only slightly influenced by voltage. At pH 6.5, the K0.5 is in the micromolar range 
for both PepT1a transporters. Zebrafish PepT1a shows K0.5 minimal value of 
0.22 ± 0.06 mmol/L at -40 mV and maximal value of 0.44 ± 0.19 mmol/L at -
120 mV. Atlantic salmon PepT1a shows higher apparent affinity for Gly-Gln 
than the zebrafish transporter with minimal value of K0.5 of 0.075 ± 0.003 
mmol/L at -60 mV and maximal value of 0.13 ± 0.01 mmol/L at -140 mV. At 
pH 7.6, the values of K0.5 increased to millimolar range and became voltage 
dependent for both transporters. By changing the cellular membrane potential 
from -140 mV to -40 mV, the K0.5 values increase about three times for 
zebrafish (from 3.55 ± 0.67 mmol/L at -140 mV to 8.63 ± 3.12 mmol/L at -40 
mV), and about six times for Atlantic salmon (from 0.42 ± 0.04 mmol/L at -140 
to 2.44 ± 0.31 at -40 mV). The PepT1a relative maximal currents elicited by 
Gly-Gln are reported in Figure 3.7B for zebrafish and in Figure 3.7E for 
Atlantic salmon. As expected from electrogenic transporters, the maximal 
relative currents Imax, of both PepT1a exhibit a clear dependence on membrane 
potential with current amplitudes that decrease passing from -140 mV to less 
negative potentials for both external pH (Figure 3.7B and 3.7E). For zebrafish 
PepT1a the rise of extracellular pH from 6.5 to 7.6 results in a pronounced 
increase in the maximal transport currents of about three-fold at -140 mV (from 
-162.78 ± 35.35 nA at pH 6.5 to -473.09 ± 59.88 nA at pH 7.6) (Figure 3.7B). 
The rise in the maximal transport rate with the increase of extracellular pH 
represents a unique feature of the zebrafish transporter as observed for the 





80mV, shows very slight differences in Gly-Gln relative maximal current values 
at two pH conditions. While, for more negative voltage values than -100 mV, 
the relative maximal current results affected by the pH showing higher 
amplitude at 7.6 than at 6.5 (Figure 3.7E). Accordingly, also the transport 
efficiency, evaluated as the ratio Imax/K0.5, is influenced largely by the pH in 
zebrafish and Atlantic salmon PepT1a (Figure 3.7C and Figure 3.7F). It shows 
higher values at pH 6.5, with a maximum at about -90 mV for zebrafish 
transporter. For Atlantic salmon transporter, the transport efficiency reaches 
higher values at more negative potentials, presumably around -160 mV. For 
both transporters, the efficiency values are smaller at pH 7.6, and the maximum 
might be reached at even more negative potentials.  
Highlighting the effect of pH on kinetic parameters, a deepest analysis was 
necessary to refine the results summarized in Figure 3.5. The dose response 
curves of Gly-Gln generated by oocytes expressing PepT1a and PepT1b of 
zebrafish and Atlantic salmon were compared at different pH conditions 
(Figure 3.8). In particular, the pH was varied from 6.5 to 7.6 in both fish, 
reaching the value of pH 8.5 for the zebrafish transporters only. The transport 
associated currents elicited by increasing the concentration of substrate from 
0.01 to 10 mmol/L at membrane potential of -60 mV were plotted as current-
concentration relationships.  Then, they were fitted with a Michaelis-Menten 
equation showing a hyperbolic behavior, with large differences between 
different pH conditions for zebrafish transporters and slighter differences for 








Figure 3.8 Fitting curves of the Gly-Gln transport associated inward currents as function of 
substrate concentration (from 0.01mol/L to 10 mol/L) and pH (pH 6.5 in green, pH 7.6 in blue 
and pH 8.5 in orange) at the membrane potential of -60mV. In Figure A and C, zebrafish 
PepT1a and PepT1b transporters (zfPepT1a and zfPepT1b). In Figure B and D Atlantic 
salmon PepT1a and PepT1b transporters (asPepT1a and asPepT1b). 
 
 
The fit is shown in Figure 3.8A and 3.8C where the dose response curves are 
represented for zebrafish PepT1a and PepT1b, respectively. In Figure 3.8B and 
3.8D, the corresponding graphs are reported for Atlantic salmon PepT1a and 
PepT1b transporters. The data show that the acidic pH affects similarly the 
function of the zebrafish proteins. Due to the high affinity to Gly-Gln of both 
zebrafish transporters at pH 6.5, the transport-associated current reaches the Imax 
value (see Figure 3.7B for PepT1a and Verri et al., 2003 for PepT1b) for Gly-
Gln concentration lower than 10 mmol/L. At pH 7.6, the current generated by 
the concentration of 1 mmol/L (indicated by the dashed line in Figure 3.8), 



























































results far from the maximum in both transporters. At this pH, the proteins 
bind the substrate with lower affinity and the current rises when the 
concentration is increased, without showing saturation in the tested range. 
When the experiments are conducted at pH 8.5, the fitted curves suggest  a 
pronounced increase in the K0.5 values; consequently, a larger amount of 
substrate is needed to reach the maximal current value, particularly for PepT1a. 
Interestingly, the transport currents elicited by concentrations of Gly-Gln up to 
1 mmol/L differ only of few nanoamperes between pH 6.5 and 7.6 for both 
transporters at membrane potential of -60 mV. Atlantic salmon transporters 
show slight differences in maximal current values at the two pH conditions. The 
fitting curves show a parallel trend for PepT1b, at pH 6.5 the current is slightly 
higher than at pH 7.6 (Figure 3.8D). For PepT1a, the fitting curves cross each 
other at concentrations higher than 1 mmol/L of Gly-Gln. According to the 
data shown in Figure 3.5 and to the data about the substrate apparent affinity 
in Figure 3.7D, the maximal current value is higher at pH 6.5 than at pH 7.6, 
for lower substrate concentrations (Figure 3.8B). Although there are only small 
differences in the current amplitude recorded at two pH conditions of about 
tens of nanoamperes, for Atlantic salmon PepT1a the highest values of maximal 
relative current are reached increasing the external concentration of Gly-Gln at 
pH 7.6, as it can be seen in Figure 3.8B. 
The detailed biophysical and kinetic analysis of transport associated currents 
highlights some characteristics that distinguish the two proteins (PepT1a vs. 
PepT1b) in each of the two fish species investigated. Further data were collected 
about the Imax, K0.5 and their ratio in the presence of Gly-Gln for zebrafish 
transporters and of Gly-Sar for Atlantic salmon PepT1a and PepT1b. During 
the experiment, two pH conditions were tested (6.5 and 7.6) at two membrane 

































































































































Table 3.1 The kinetic parameters: K0.5, Imax and the transport efficiency (Imax/K0.5). Data are 
obtained from Xenopus laevis oocytes for clamped voltages of -60 mV and at -120 mV, when 
perfused with Gly-Gln in sodium chloride buffer solutions at pH 6.5 and 7.6/7.5. The values are 
expressed as the averages ± SEM of n oocytes reported (each oocyte represents an independent 
observation). The kinetic parameters were calculated using the least-square fit of the Michaelis-
Menten equation, Figure 3.7. The percentage of substrate present in its neutral (zwitterionic) 
form at a given pH is calculated using the Henderson-Hasselbach equation and the following 
pKa values: pKa1 = 2.88, pKa2 = 8.29 for Gly-Gln and pKa1 = 2.83, pKa2 = 8.45 for Gly-Sar. 
(*) For comparison, the kinetic parameters of Atlantic salmon PepT1b are reported, as extracted 







Notably, all the changes in both Imax and K0.5 result in a consistent reduction of 
zebrafish and Atlantic salmon PepT1a transport efficiency (Imax/K0.5). In all the 
tested conditions, the transport efficiency is systematically lower that that 
recorded for the corresponding PepT1b transporters. 
Data about the Imax, K0.5 and their ratio for Atlantic salmon PepT1a were 
collected also in the presence of Ala-Ala, Gly-Asn, and Gly-Pro at pH 6.5 and 
are summarized (compared to Gly-Gln and Gly-Sar) in Table 3.2. 









Gly-Gln 0.076 ± 0.004 -41.317 ± 0.835 546 9-12/2 
Gly-Sar 0.523 ± 0.102 -39.228 ± 4.490 75 9/3 
Ala-Ala 0.024 ± 0.005 -18.404 ± 0.759 736 8/2 
Gly-Asn 0.237 ± 0.106 -39.486 ± 7.099 167 9/2 
Gly-Pro 0.317 ± 0.118 -26.479 ± 5.219 84 7/2 
 
Table 3.2 The kinetic parameters of the inwardly directed transport of the selected 
di/tripeptides via the Atlantic salmon PepT1a (Slc15a1a). They were measured in Two-Electrode 
Voltage Clamp (TEVC) experiments. All values are expressed as the average ± SEM of n 
oocytes reported (each oocyte represents an independent observation). Xenopus laevis oocytes 
were voltage clamped at -60 mV and perfused with solutions at pH 6.5. The kinetic parameters 
















Figure 3.9 Comparison of PepT1 pre steady-state currents from mammalian (rabbit, rbPepT1) 
and two teleost fish species (zebrafish, zfPepT1a and zfPepT1b; Atlantic salmon, asPepT1a and 
asPepT1b). Voltage pulses, in the range from -140mV to +20mV, were applied starting from 
voltage holding of -60mV at pH 6.5. In absence of organic substrate (top), all tested transporters 
display transient currents in “on” and “off” of rectangular voltage jumps. In the presence of 3 




The pre steady-state (PSS) currents of rabbit PepT1, and zebrafish PepT1b  
have been already described and analyzed (Nussberger et al., 1997; Renna et al., 
2011b), while those of Atlantic salmon PepT1b have not been investigated yet. 
The parameters that can be derived from these currents are crucial to 
understand the kinetics of the transport cycle steps.  
  Gly-Gln 
    3mmol/L0,1 s
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The PSS of the newly cloned PepT1a transporters and PepT1b of Atlantic 
salmon were recorded and compared to the transient currents of well-known 
transporters: zebrafish PepT1b and rabbit PepT1. The experiments were 
performed on X. laevis oocytes expressing the proteins, under voltage pulses of 
20 mV from -140 to +20 mV both in absence and in the presence of Gly-Gln (3 
mmol/L), at pH 6.5. As shown in Figure 3.9, PepT1b of Atlantic salmon, 
similarly to what was previously reported for the zebrafish PepT1b and also for 
the seabass PepT1 transporter (GenBank Acc. No. FJ237043; Sangaletti et al., 
2009), exhibit slow decaying, better visible for the “on” and “off” 
hyperpolarization voltage steps (from -140 mV to -80 mV) than in 
depolarization condition (from -40mV to +20 mV). Surprisingly, the transient 
currents of PepT1a transporters, similarly to the rabbit transporter, show 
symmetric behavior around the holding potential of -60 mV. The transient 
currents in response to the “on” and “off” voltage steps are well defined and 
particularly slow. This behavior is more emphasized in the zebrafish transporter. 
The traces in Figure 3.9 (bottom) show the switch of the PSS to steady state 
transport currents in the presence of 3 mmol/L of Gly-Gln substrate at 
saturating concentration. Under this experimental condition, the PSS are almost 
completely abolished in all proteins, except for zebrafish PepT1a.  
The PSS currents in PepT1 transporters, analyzed so far, shows a marked 
dependence on extracellular pH, in fact in rabbit and seabass PepT1 and in 
zebrafish PepT1b, increasing pH values of external medium has been shown to 
accelerate the decay of the PSS currents. This happens also in PepT1a 
transporters, as shown by the representative traces of Figure 3.10. At pH 7.6, 
both PSS of PepT1a transporters lost the symmetry around the holding 
potential. The transients become more observable in hyperpolarization than in 
depolarization. Even in Atlantic salmon PepT1b, the changes in external pH 
from 6.5 to 7.6 greatly accelerate the decay of transient currents. These 





(τ/V) and the charge vs. potential (Q/V) curves at the two different pH 
conditions, in the right side of Figure 3.10 
. 
  
Figure 3.10 Current traces and pre steady-state currents analysis for zebrafish PepT1a 
(zfPepT1a), Atlantic salmon PepT1a (asPepT1a) and PepT1b (asPepT1b). In the left side, there 
are the representative traces of currents elicited by voltage pulses in the range -160 to +20 mV 
(20 mV steps from Vh of -60 mV) in absence of substrate at pH 6.5 and pH 7.6. In the right 
side, there are the analysis of pre steady-state currents reported as /V and Q/V. The time 
constants () were obtained from the slow component of a double exponential fitting of the 
traces in absence of the substrate (the values were estimated from the “on” transients, except for 
the value at -60 mV (Vh), which was estimated from the “off” transients). The charge vs. voltage 
curves were obtained by integration of the transient isolated at the two pH values (“on” and 
“off” integrals were averaged for each individual oocyte before calculating the cumulative mean). 







































































































The voltage dependences of the time decay constant τ and the intramembrane 
moved charge Q are obtained from the isolated PSS currents, using double 
exponential function fitting the currents recorded in the absence of substrate 
(Sangaletti et al., 2009). This method allows to separate transporter-PSS currents 
from the fast peaks due to the endogenous oocyte capacity. As for the 
mammalian transporter rabbit PepT1, the τ/V curves of both fish PepT1a are 
bell-shaped with a maximum at about -60 mV, at pH 6.5. This confirms the 
symmetrical behavior of transient current around the holding potential. For 
Atlantic salmon PepT1b, the analyses of the time decay constant as function of 
voltage show only a right half of bell-shaped curve at pH 6.5 and it appears to 
have a maximum at about -140 mV, as observed for the already characterized 
transporters in other teleost fish species (Renna et al., 2011b). For all 
transporters, the change of external pH to 7.6 produces negative shifts in the 
τ/V. The maximum is reached at about -120 mV for PepT1a transporters, 
whereas the maximal value of τ for Atlantic salmon PepT1b might be found at 
even more negative voltages. Furthermore, the levelling of τ/V curves at pH 7.6 
is a consequence of an acceleration in the decaying of the PSS currents that are 
faster for Atlantic salmon PepT1b than for PepT1a transporters.  
The moved charge Q is computed as the integral of the transient currents over 
time. The values reported are the average of the values obtained for the “on” 
and the “off” responses. 
When plotted, the charge vs. voltage (Q/V) curves show a clear sigmoidal shape 
at pH 6.5 for both PepT1a transporters, whereas in the Atlantic salmon PepT1b 
only the rightmost part of sigmoid is visible. This evidence confirms once again 
the similarity of the PepT1a transporters to the mammalian orthologue as well 
as the similar behavior of the PepT1b transporter with the seabass PepT1 and 
PepT1b of zebrafish. Moreover, the alkalization of the external medium 
produces negative shift for both PepT1a and PepT1b transporters in charge vs. 





To analyze the transient currents of transporters and to better understand their 
significance, it can be assumed that the transporter charge (intrinsic or extrinsic) 
can be in two-states (“In” and “Out”) within the electrical membrane field. The 
charge vs. voltage curves represent the probability of the distribution of 
transporters between these two possible conformations/positions. The 
probability to be in one or in the other state is related to the differences in the 
voltage across the membrane. The charge movement process can be described 
with the simple reaction [3.1] where the outrate and the inrate are the 
unidirectional rate constants. Qin is the amount of charge located near the inner 
side of the membrane electrical field and Qout is the amount of charge displaced 
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In order to facilitate the subsequent analysis and for taking into account the 
correction due to the different levels of transport proteins functionally 
expressed in plasma membranes of oocytes, the data of charge vs. voltage in 
Figure 3.10 were normalized against the maximal moveable charge Qmax. The 
Qmax of different transporters were obtained by fitting using the Boltzmann 
function [3.2], and the unitary charge level (Q =1) was set to the saturation 
value at positive potential (Qin). 
 













Q                                [3.2] 
 
The Boltzmann equation describes the equilibrium distribution of the moved 





from saturating values of Q/V sigmoidal curve. For the experiments in which it 
was not possible to reach the saturation values of Q/V curves at hyperpolarized 
potentials, the Qmax was predicted by fitting the available data of the Q/V curve 
with the sigmoidal equation. V0.5 is the voltage at which half of the maximal 
charge is moved (the midpoint of the Q/V sigmoidal). σ = kT/q  represents a 
slope factor, in which q is the elementary electronic charge, k is the Boltzmann 
constant, T is the absolute temperature, and  is the fraction of electrical field 
over which the charge movement occurs (Renna et al., 2011b).  
The parameters obtained by fitting of charge vs. voltage curves (Q/V) with the 
Boltzmann function (Qin and Qmax) and the time decay constant vs. voltage 
curves (τ/V) can be used to determine the unidirectional inward, and outward 
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In Figure 3.11, The voltage- and pH-dependence of the unidirectional rate 
constants for zebrafish PepT1a and Atlantic salmon PepT1 transporters are 
reported.  Assuming a positive mobile charge, the outward rates increase when 
the inner side of cellular membrane presents a positive voltage and decrease to 
zero for membrane voltage values lower than -100/-140 mV.  Conversely, the 
inward rates increase and decrease respectively with hyperpolarization and 
depolarization of the membrane potential. At pH 6.5, the outward and the 
inward rates of both zebrafish and Atlantic salmon PepT1a are slightly voltage 





the range from -80 mV to -40 mV in agreement with τ maximal value at this pH. 
At the same pH condition, Atlantic salmon PepT1b shows an asymmetric 
behavior of the outward and inward voltage curves. 
 
 
Figure 3.11 The unidirectional rate constants, inward (open symbols) and outward (solid 
symbols), of the intramembrane charge movement of zebrafish PepT1a (zfPepT1a) and Atlantic 
salmon PepT1 transporters (asPepT1a and asPepT1b). The decay rates were derived from the 
time constant and the charge at the two pH conditions (pH 6.5 green square and pH 7.6 blue 
circle) and were plotted as function of membrane potentials, in the range from −160 mV to +20 
mV. Data are the mean ± SE from 5 to 15 oocytes. 
 
 
The inward rate is affected slightly by voltage, while the outward rate is strongly 
voltage dependent with great acceleration recorded at positive membrane 
potentials. Changing external pH from 6.5 to 7.6, the outward rates become 
highly voltage dependent and faster when the membrane potential is made more 
positive in both PepT1a transporters.  
For zebrafish PepT1a the inward rate vs. voltage curve slightly increases at pH 
7.6 with respect to pH 6.5. Independently from the voltage tested, no 
differences between the two pH conditions are observed on the inward rate vs. 
voltage curves for Atlantic Salmon PepT1a.  



























































The increase of external pH from 6.5 to 7.6 increase similarly the inward and 
outward rates in Atlantic salmon PepT1b (for the inward rate at -140 mV the 
ratio is 0.4, while for the outward rate at +20 mV the ratio is 0.6). 
Furthermore, the decay rates of both fish PepT1a transient currents are like 
those of rabbit PepT1 and are much slower than those previously described for 
both zebrafish and the Atlantic salmon PepT1b as well as for the seabass PepT1 
(Renna et al., 2011b). To summarize and to compare the data obtained by the 
analysis of the PSS currents of the mammalian PepT1 and the fish PepT1a and 
PepT1b transporters, the parameters obtained by fitting with the Boltzmann 
equation [3.2] and the Q/V curves are reported in Table 3.3. 
 
 Qmax (nC)  V0.5 (mV)  σ (mV) 
 6.5 7.5 - 7.6  6.5 7.5 - 7.6  6.5 7.5 - 7.6 





























































Table 3.3 The Boltzmann equation parameters of rabbit PepT1 (rbPepT1), zebrafish PepT1 
transporters (zfPepT1a and zfPepT1b) and Atlantic salmon PepT1(s) (asPepT1a and asPepT1b). 
Qmax is the maximal moveable charge, V0.5 is the voltage at which half of the charge is moved, σ 
represents a slope factor of sigmoidal curve. The parameters are calculated at two pH 
conditions: at pH 6.5 and pH 7.5 for rabbit PepT1 and zebrafish PepT1b (Renna et al., 2011b); 







It is worth to mention that the slope factor σ in the Boltzmann model relates to 
the apparent charge moved and gives information about the “position” of the 
proton binding site based on the two states model [3.1].   
 
 
Transport of charged substrates and dipeptides containing essential 
amino acid (EAA) 
 
PepT1 transporters are known to bind several di- and tripeptide substrates 
possessing several different charges. The human PepT1 mediates the active 
transport of neutral, cationic and anionic dipeptides in a H+ dependent manner 
(Amasheh et al., 1997). The interaction of differently charged dipeptides with 
the transporter’s substrate binding site is strongly dependent on the position of 
the charged amino acid (Vig et al., 2006) and it is strongly dependent on external 
pH (Amasheh et al., 1997). In rabbit (Kottra et al., 2002) and seabass PepT1 
(Margheritis et al., 2013) the amplitude of the transport current increases for 
lysine containing dipeptides with the charged residue in the amino-terminus 
position. These transport currents at fixed substrate concentration of 1 mmol/L 
for both rabbit and seabass PepT1 have been found to be slightly dependent on 
the alkalinity or acidity of the external solution. In zebrafish PepT1b, the 
transport associated currents for lysine containing dipeptides are regulated by 
the pH of external solution  (Margheritis et al., 2013). In the context of the 
comparative analysis on substrate selectivity between PepT1a and PepT1b 
transporters, the transport associated current in the presence of different 
charged peptides were recorded. To investigate the importance of the position 
of the charged residue in the interaction with the PepT1 protein, the 
experiments were conducted in the presence of specific charged dipeptides, with 
the charged amino acid residue in either the amino- or in the carboxy-terminal 
position. These experiments were performed at pH 7.6. The data collected are 





and in Figure 3.12B and 3.12C for two couples of cationic substrates Gly-
Lys/Lys-Gly and Met-Lys/Lys-Met, respectively. The recordings at -60 mV 
were normalized to the current elicited by 1 mmol/L of neutral reference 
substrate, Gly-Gln, for each tested transporter allowing to rapidly compare 
similarities and differences among PepT1a and PepT1b.  
Anionic dipeptides- In the representative traces and in the histogram reported in 
Figure 3.12A, the Asp-Gly evokes larger currents in PepT1a expressing oocytes 
if comparted to the current in the presence of reference substrate Gly-Gln. 
Conversely the same substrate elicited only very small current in zebrafish 
PepT1b transporter and a current smaller than Gly-Gln in Atlantic salmon 
PepT1b transporter. For both PepT1a transporters, changing the position of 
negative charge residue, i.e. in dipeptide Gly-Asp, the amplitude of the 
transport-associated current is reduced, becoming equal to the reference current 
generated by Gly-Gln. The currents evoked by the two anionic substrates show 
comparable values in PepT1b transporters suggesting in this case that the 
position of the charge residue in the dipeptide it is not a discriminating factor 
for the transport activity. Even if in zebrafish PepT1b the currents elicited by 
the two anionic substrates have a reduced amplitude. 
Cationic dipeptides- Currents recorded in the presence of dipeptides containing 
lysine and glycine show that the position of the charged residue establishes the 
amplitude of the transport current for both PepT1b; in fact, when the current 
evoked by Gly-Lys and Lys-Gln are compared, the transport current are always 
larger in the presence of Lys-Gly (Figure 3.12B). When the neutral amino acid 
is methionine, the importance of the charge position is confirmed in Atlantic 
salmon PepT1b (Figure 3.12C). Notably, the current evoked by Lys-Met is 
higher than the current in the presence of Met-Lys. Instead, the charge position 
is not essential in zebrafish PepT1b in which the Lys-Met and Met-Lys show 
comparable currents (Figure 3.12C). Moreover, except for the Gly-Lys, in 






Figure 3.12 Transport current elicited by differently charged dipeptides compared with Gly-Gln 
(GQ) (all at 1 mmol/L) for the indicated PepT1 transporters: zebrafish PepT1a and PepT1b 
(zfPepT1a, zfPepT1b), Atlantic salmon PepT1a and 1b (asPepT1a and asPepT1b). The 
transport current elicited by Gly-Asp and Asp-Gly (GD, DG) in A, by Gly-Lys and Lys-Gly 
(GK, KG) in B, by Met-Lys and Lys-Met (MK, KM) in C were recorded at the holding potential 
of -60 mV and at pH 7.6. In the left part of all figures representative traces of transport current 
induced by the presence of each substrates indicated by the differently colored bars. In the right 
part of A, B and C the mean of the transport associated current were normalized respect Gly-
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the reference substrate (Gly-Gln). The same substrates in zebrafish PepT1b 
generate small (for Lys-Gly) or similar (as for both Met-Lys and Lys-Met) 
currents to those generated by Gly-Gln. For both PepT1a, the transport 
currents in the presence of all the tested cationic peptides are always smaller 
than Gly-Gln currents and are not influenced by the position of the positive 
charge residue in dipeptide (Gly-Lys and Lys-Gly in Figure 3.12B; Met-Lys and 
Lys-Met in Figure 3.12C).  
To verify how the membrane voltage affects the transport of differently charged 
dipeptides, zebrafish and Atlantic salmon transporters were tested in the 
presence of 1 mmol/L of anionic dipeptides (Asp-Gly and Gly-Asp), and 
cationic dipeptides (Lys-Gly and Gly-Lys) applying the pulse protocol (step of 
20 mV from -140 to +20 mV). The currents in the presence of the tested 
substrates were normalized to the Gly-Gln current value at the membrane 
potential of -140 mV. According to the Henderson-Hasselbalch equation, the 
percentage of each substrate species as function of pH was calculated to have 
about 98% of the molecules in the charged form. The transport currents of 
anionic substrates and cationic substrates were recorded at pH 7.6 and pH 6.5, 
respectively. 
I/V relationships of anionic dipeptides- Except for zebrafish PepT1b, all the tested 
transporters show voltage dependent currents in the presence of both Asp-Gly 
and Gly-Asp with an increment of the inward currents recorded from +20 mV 
to -140 mV (Figure 3.13A). 
According to the values of the current at -60 mV, Asp-Gly evokes higher 
current than Gly-Gln at all the tested potentials in zebrafish PepT1a, but not in 
Atlantic salmon PepT1a, where the I/V relationships are similar between Asp-
Gly and Gly-Gln with a slight decrease of Asp-Gly current at the negative 
voltage condition of -140 mV. For both PepT1a transporters, the comparison of 
the I/V curve of Gly-Asp with the reference curve shows a similar behavior 





the hyperpolarization conditions from -100 mV to -140 mV. In PepT1b 
transporters, the I/V relationships are similar between the anionic dipeptides, 
with the currents always smaller than that elicited by Gly-Gln. In Atlantic 
salmon PepT1b an increase of Asp-Gly and Gly-Asp currents is observed at the 
most hyperpolarizing membrane potentials. At the same conditions only a slight 
increase of the transport currents is observed in zebrafish transporter. 
 
 
Figure 3.13 Current-voltage (I/V) relationships of transport-associated currents in the presence 
of 1 mmol/L of aspartate- and lysine- containing dipeptides in zebrafish (zfPepT1a and 
zfPepT1b, top) and in Atlantic salmon (asPepT1a and asPepT1b, bottom) transporters. In A 
I/V in the presence of Asp-Gly (DG, orange-down triangles), Gly-Asp (GD, yellow-up 
triangles) and Gly-Gln (GQ, gray circle) at pH 7.6. In B I/V in the presence of Lys-Gly (KG, 
dark cyan-left triangles), Gly-Lys (GK, light cyan-right triangles) and Gly-Gln (GQ, gray-circle) 
at pH 6.5. The currents elicited by voltage pulses in the range from -140 to +20 mV (20 mV 
steps from Vh of -60 mV) are obtained by subtracting from the current in the presence of 
substrate, the current in its absence and are presented as mean ± SE from 7 to 15 oocytes from 
different batches normalized respect to the current value of Gly-Gln at -140mV.  
 
 
I/V relationships of canionic dipeptides- The cationic dipeptides do not give rise to 
any currents at all tested potentials for both PepT1a transporters, whereas 
A                                                              B 




























































































































species-specific differences are observed comparing I/V curves in the presence 
of cationic dipeptides between PepT1b transporters particularly in the presence 
of Lys-Gly (Figure 3.13B). With respect to the reference substrate, Lys-Gly is 
the best substrate at all tested potentials in Atlantic salmon transporter, while in 
zebrafish PepT1b it shows always smaller current than those of Gly-Gln. For 
both PepT1b transporters at all tested potentials, Gly-Lys elicits small current 
with respect to the current of Gly-Gln. Moreover, in zebrafish PepT1b the 
position of charged residue in dipeptide influences the voltage-dependence of 
the current amplitude in the range from -80 mV to -140 mV with larger current 
recorded in the presence of Lys-Gly than in the presence of Gly-Lys.  
To completely characterize the PepT1a protein and their role in transporting 
important nutritional peptides such as lysine and methionine containing 
dipeptides, they were tested under the same experimental conditions reported in 
(Margheritis et al., 2013). The same was done for Atlantic salmon PepT1b. 
The membrane voltage and the external pH dependence of the transport 
currents were investigated using the pulse protocol at two different pH 
conditions. The current voltage relationships at pH 6.5 and 7.5 for zebrafish 
PepT1a and Atlantic salmon transporters are illustrated in Figure 3.14. 
In Atlantic salmon PepT1b, the current generated by Gly-Lys at two pH values 
are significantly different (p<0.001) in the potential range from -20 mV to -140 
mV, with higher current values at pH 6.5 (Figure 3.14A). The current evoked 
by Lys-Gly, Met-Lys and Lys-Met are affected by external pH in function of the 
membrane potential. In fact, the current values in the range of -20 mV to -60 
mV are higher at pH 6.5 than those at pH 7.6, with significant differences in 
amplitude of currents at -20 mV (p<0.001 for Lys-Gly and Met-Lys and p<0.05 
for Lys-Met). At the most negative voltages tested (-120 mV and -140 mV), the 
currents increase in the presence of the same substrates from pH 6.5 to 7.6, with 
significantly different values at -140 mV (p<0.001 for Lys-Gly and p<0.05 for 





transporters no effect of pH is observable in Gly-Lys and Lys-Gly induced 
currents, (see Figure 3.14I and 3.14L for zebrafish transporter, 3.14E and 
3.14F for Atlantic salmon PepT1a). The only exception is the Lys-Gly, in fact 
this dipeptide gives rise to a current significantly higher at pH 7.6 at -140mV 
(p<0.01) in Atlantic salmon PepT1a (Figure 3.14F).  When the substrate is the 
Met-Lys, the pH effect on the current voltage relationship is similar in both 
PepT1a transporters. In fact, the transport currents are significantly higher at 
pH 6.5 in the range from -20 mV to -100mV (with p<0.001 at -20 mV and 
p<0.01 at -100 mV) for Atlantic salmon (Figure 3.14G). For zebrafish, the 
transport currents are significantly high at pH 6.5 in the range from -20 mV to -
120mV (with p<0.001 at -20 mV and p<0.05 at -120 mV), (Figure 3.14M). For 
both PepT1a, once set the membrane voltage at -140 mV and external pH at 
7.6, the current evoked by Lys-Met apparently increases without statistically 
significant difference respect to the current recorded at pH 6.5 (Figure 3.14N). 
The same substrate in the voltage range from -20 mV to -60mV shows currents 
higher at pH 6.5 than those at pH 7.6 with significant differences for Atlantic 
salmon PepT1a (p<0.001 at -20 mV and p<0.05 at -60 mV); no statistically 









Figure 3.14 Current-voltage (I/V) relationships of transport-associated currents in the presence 
of lysine containing peptides in Atlantic salmon PepT1b (asPepT1b) in A-D and in Atlantic 
salmon PepT1a (asPepT1a) in E-H and in zebrafish PepT1a in I-N (zfPepT1a). The currents 
elicited by voltage pulses in the range -140 to +20 mV (20 mV steps from Vh of -60 mV) were 
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recorded in the presence of 1 mmol/L of different substrates (Gly-Lys (GK) in A, E and I; Lys-
Gly (KG) in B, F and L; Met-Lys (MK) in C, G and M; Lys-Met (KM) in D, H and N) at pH 
6.5 (light gray symbols) and pH 7.6 (empty symbols). Gly-Gln (GQ) values at pH 7.6 are 
reported as reference (dark gray symbols). The current value reported in I/V relationship were 
the obtained by subtracting from the current in the presence of substrate, the current in its 
absence. Data are reported as mean ± SE from 8 to 11 oocytes from different batches. 
 
 
To better understand the behavior of the two Atlantic salmon PepT1 
transporters in the presence of lysine containing peptides, the transport currents 
for Lys-Gly were collected perfusing the oocytes expressing PepT1a and 
PepT1b with increasing concentration of substrate from 0.1 to 30 mmol/L at 
pH values of 7.6 at the holding potential of -60 mV.  
 
 
Figure 3.15 Inward currents in Xenopus laevis oocytes expressing Atlantic salmon PepT1a 
(asPepT1a) in A, and Atlantic salmon PepT1b (asPepT1b) in B. The currents were recorded at 
the holding potential (Vh) of -60 mV at pH 7.6. The oocytes were perfused consecutively with 
increasing concentrations of the Lys-Gly from 0.1 mmol/L to 10 mmol/L for PepT1b and to 30 
mmol/L for PepT1a. The top bars indicate the substrate administration and the bottom arrows 
indicate the different concentration of substrate. The current of reference substrate Gly-Gln at 3 




































In oocytes expressing the Atlantic salmon PepT1b, the currents elicited by 1 
mmol/L Lys-Gly are larger than the currents in the presence of Gly-Gln 3 
mmol/L. The increasing Lys-Gly concentrations further enhanced the transport 
current (Figure 3.15B). The same concentration of 1 mmol/L Lys-Gly on 
PepT1a expressing oocytes gave rise only to small currents and in the presence 
of 30 mmol/L the current was similar to that in the presence of Gly-Gln 3 
mmol/L (Figure 3.15A). If the same concentrations of Lys-Gly were tested 
from -140 to 0 mV, the current vs. concentration relationships showed that for 
PepT1a the maximal current was never reached at the tested voltages (Figure 
3.16A). Moreover, in the presence of the Lys-Gly 30 mmol/L, the Atlantic 
salmon PepT1a showed residual PSS currents (Figure 3.16C). Conversely, 
Atlantic salmon PepT1b currents in the presence of 1 mmol/L of Lys-Gly were 
similar to those recorded at higher substrate concentrations at all tested 
potentials (Figure 3.16B). Moreover, the absence of PSS currents in the 
presence of 1 mmol/L of Lys-Gly confirms the saturation of the transport 








Figure 3.16 Current-substrate concentration relationships at different voltage conditions in 
Atlantic salmon PepT1a in A and PepT1b in B. The current values at each tested concentration 
of Lys-Gly (from 0.1 mmol/L to 10 mmol/L for PepT1b and to 30 mmol/L for PepT1a) were 
obtained by subtracting the current traces in absence of the substrate to those occurring in its 
presence. Data are reported as mean ± SEM of 10 or 12 oocytes from 3 batches. In C and D 
respectively: the representative traces of Atlantic salmon PepT1a and PepT1b in the absence of 
substrate (in the left part of figure C and D) and in the presence of 30 mmol/L of Lys-Gly for 
PepT1a (in the right part of figure C) and in the presence of 1 mmol/L of Lys-Gly for PepT1b 
(in the right part of figure D).  
 
 
The current-substrate concentration relationships were used to determine the 
kinetic parameters by the fitting with the Michaelis-Menten equation. The 
relative apparent affinity (1/K0.5) values for Atlantic salmon PepT1b transporter 
are reported as function of potential (Figure 3.17A). Changing the cellular 
membrane potential from -140 mV to 0 mV, the K0.5 values increase 
progressively from the minimal value of 0.18 ± 0.01 mmol/L recorded at -140 



















































mV to the maximal value 7.463 ± 2.16 mmol/L recorded at 0 mV. As expected, 
the maximal relative current is influenced by membrane potentials with the 
maximal value reported of -827.24 ± 17.33 nA at -140 mV (Figure 3.17B).  
The lack in transport saturation for PepT1a impeded to determine the kinetic 
parameters for this transporter; only values at -140 and -120 mV have been 
estimated, as reported in the insert in Figure 3.17. 
In Figure 3.17A(a), there are the estimated values of relative apparent affinity 
(10.36 ± 1.19 mmol/L at -120 mV and 6.33 ± 0.78 mmol/L at -140 mV) and in 
Figure 3.17B(b), there are the values of the maximal relative current (-149.07 ± 
8.26 nA at -120 mV and -173.34 ± 9.54 nA at -140 mV). The transport 
efficiency was calculated only for PepT1b and reported in Figure 3.17C. 
 
 
Figure 3.17 Dose response analysis of Atlantic salmon PepT1b: K0.5, Imax and transport 
efficiency, respectively in A, B and C evaluated in the presence of Lys-Gly. The current values 
(Figure 3.16) were subsequently fitted with the Michaelis-Menten equation [𝐼0 = −𝐼𝑚𝑎𝑥1+([𝑆] 𝐾0.5 ⁄ ) +𝐼𝑚𝑎𝑥] to obtain the apparent relative affinity (1/K0.5) and the maximal relative current (Imax) and 
transport efficiency (Imax/ K0.5) at each indicated voltage and at pH 7.6. In A and B, the inserts 
(Aa and Bb) there are the estimations of kinetic parameters at -120 mV and -140 mV for 
Atlantic salmon PepT1a transporter. 
 
 


























































































For the zebrafish PepT1a transporter, the dose response experiments were 
performed in the presence of the cationic dipeptide Lys-Gly and the anionic 
dipeptide Gly-Asp. The experimental substrate and pH condition were the same 
reported for PepT1b (Verri et al., 2003) to permit the comparison. The kinetic 
parameters for zebrafish PepT1a were obtained from a few numbers of oocytes 
of batch, therefore these data are to be considered as preliminary and they are 
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Table 3.4 The kinetic parameters of the inwardly directed transport of cationic and anionic 
dipeptides via the zebrafish PepT1a measured in Two-Electrode Voltage Clamp (TEVC) 
experiments. All values are expressed as mean ± SEM of n oocytes (each oocyte represents an 
independent observation). Xenopus laevis oocytes were voltage clamped at -60 mV and at -120 
mV and perfused with solutions at the indicated pH conditions. The kinetic parameters (K0.5 and 
Imax) were calculated by least-square fit to the Michaelis-Menten equation. All amino acids were 
L-type. The percentage of the zwitterionic form at a given pH was taken from Kottra et al. 
(2002). To facilitate the comparison, kinetic parameters of zebrafish PepT1b are reported in the 







Chapter 4. Discussion 
 
 
PepT1 transport proteins have been studied from functional and structural 
points of view and a huge amount of data are available about their expression 
and regulation in different species. The electrophysiological results on the 
transport activity of several PepT1 orthologues show many functional 
differences in the various species. Particularly, the functional characterization 
of PepT1 from teleost fish exhibited transport peculiar transport properties 
that are species-specific in fish and differ with respect to the mammalian 
counterparts. The functional plasticity found in fish orthologues reflects the 
molecular adaptation of the PepT1 transporter to the astonishing range of 
habitats  and/or of anatomical peculiarities which characterize each species 
(Romano et al., 2014). Moreover, the specific whole duplication event 
occurred during Actinopterygian lineage evolution have led to a more 
complex gene repertoire in teleost fish than in higher vertebrates. This aspect 
represents a great and important value for studies in fish model organisms. 
The identification of the PepT1-type paralogues named PepT1a and PepT1b 
suggests that in teleost fish more than one PepT1-type protein might be 
expressed and might function as transport system. Functional data available 
in literature on teleosts are referred to PepT1b-type only, such as for 
zebrafish (Verri et al., 2003), seabass (Sangaletti et al., 2009), ice fish (Rizzello 
et al., 2013) and Atlantic salmon PepT1b transporters (Ronnestad et al., 
2010). 
Recently, the complementary DNAs coding for PepT1a-type transporters 
have been cloned from the gut of zebrafish and Atlantic salmon. By sequence 
analysis, the two predicted PepT1a proteins share about 80% similarity and 
about 60-65% identity with their species paralogue PepT1b.  The functional 
characterization of the newly cloned PepT1a-type transporters performed by 





Overexpression of PepT1a-type and PepT1b-type transporters in X. laevis 
oocytes allows precise electrophysiological transport measurement and the 
comparison between PepT1 transporters, emphasizing similarities and 
differences in the kinetic mechanism of the new PepT1a transporters with 
respect to the well-characterized PepT1b(s) and mammalian PepT1. 
These studies are important not only for relating the physiological role of 
each transporter to its kinetic parameters but also to functionally identify 
regions and residues that confer specific macroscopic features. In this 
respect, the kinetic differences between transporters that show high 
similarities, such as paralogue or orthologue products, are invaluable tools. 
These evidences, together with structural data collected mainly from bacterial 
orthologues, deepen the description of the steps of translocation of 
substrates and drugs (Newstead, 2017b). Despite the oocyte internal pH and 
external temperature are important factors in determining the transport 
kinetics of PepT1 (Nussberger et al., 1997; Bossi et al., 2012), in this work 
the oocyte internal pH is assumed to be constant (assuming a fixed value of 
7.5 pH). All experiments were conducted at the external temperature range 
from 18°C to 20°C according to the experimental procedures of oocytes. 
Recording the transport currents at fixed voltage, it has been demonstrated 
that the zebrafish and Atlantic salmon PepT1a transporters are electrogenic 
and capable of transporting di and tripeptides in a proton dependent manner. 
Moreover, in Figure 3.4, the overlapping of I/V relationship obtained with 3 
mmol/L Gly-Gln in sodium and sodium-free solutions shows that PepT1a 
transporters mediate translocation of substrate independently of the presence 
of sodium in the external environment. Considering that in the first 
experiments the currents were recorded: i) at fixed membrane potentials of -
60 mV, ii) at different pH conditions (6.5, 7.6 and 8.5), and iii) with perfusion 
of 1 mmol/L Gly-Gln, Ala-Ala and Gly-Gly-Gly, the representative traces 





(Figure 3.5) clearly indicate that the differences in amino acid sequence, 
between PepT1a and PepT1b transporters, have functional implication(s) 
both in pH dependence and in substrate preferences. In fact, if compared to 
the well-characterized PepT1b transporter of zebrafish, the protein PepT1a: 
i) prefers Ala-Ala to Gly-Gln; ii) works well at acidic pH; iii) gives rise to 
relatively smaller currents in all conditions tested; iii) produces currents of 
few nanoamperes for Gly-Gly-Gly regardless of the pH conditions. 
When transport currents are compared between transporters of Atlantic 
salmon, PepT1a shows a more marked pH dependence than PepT1b. In fact, 
Atlantic salmon PepT1a works well at acidic pH with transport currents that 
differ statistically between pH 6.5 and 7.6, for all tested substrates.  
However, while eliciting transport currents, the 1 mmol/L substrate 
condition is not the most adequate for testing the transporter pH 
dependence, because of the considerable effect of protons on the substrate 
affinity. When the transport associated currents are recorded in the presence 
of increasing concentrations of Gly-Gln using the standard step protocol, the 
rising of pH increases the amount of substrate necessary to reach the 
maximal current amplitudes greatly increasing the current value (Figure 3.6). 
The Gly-Gln transport follows the Michaelis Menten saturation kinetics for 
both zebrafish and Atlantic salmon PepT1a transporters. Moreover, the 
maximal relative current (Imax) and the apparent affinity (1/K0.5) values are 
affected differently by membrane potential and external pH (Figure 3.7). 
Regarding Imax, the Atlantic salmon PepT1a is affected only slightly by pH 
(Figure 3.7E), with an increase in Imax at pH 7.6 observed when the 
membrane potential is clamped at hyperpolarization values, from -100 mV to 
-140 mV. 
Conversely, Imax of zebrafish PepT1a is affected largely by external pH, with 
the maximal transport activity always higher at pH 7.6 than pH 6.5 regardless 





K0.5 values are in the hundreds of the micromolar range and result only 
slightly voltage-dependent at pH 6.5 (Figure 3.7Aa and 3.7Dd). At pH 7.6, 
the K0.5 values increase to millimolar range and are strongly voltage 
dependent (Figure 3.7A and 3.7D).  
The data on kinetic parameters of zebrafish and Atlantic salmon PepT1a 
transporters show that PepT1a-type represents a classical low-affinity/high-
capacity system. When the extracellular pH is raised from 6.5 to 7.6, the 
increase in the maximal transport activity is confirmed to be a peculiar 
feature of the zebrafish transporters (Verri et al., 2003; Nalbant et al., 1999). 
Interestingly, Atlantic salmon PepT1a exhibits only a slight increase of 
maximal transport current changing the pH from 6.5 to 7.6, almost similar to 
Atlantic salmon PepT1b (Ronnestad et al., 2010). 
The observed pH dependencies on maximal transport rates may be related to 
the actual pH values found in the intestinal lumen, which is alkaline under 
normal physiological conditions in both zebrafish and Atlantic salmon. Both 
these teleost species are carnivorous fish, with a short intestinal tract. Like 
other cyprinids and salmonids respectively, zebrafish and Atlantic salmon 
possibly have no or only very low levels of mRNA of NHE3 in enterocytes 
(Ronnestad et al., 2010; Verri et al., 2003). This lack contributes to create the 
alkaline microenvironment at apical membrane level where PepT1 operates. 
Moreover, the emphasized response to extracellular alkalinisation of the 
zebrafish PepT1 transporters could be explained by the occurrence of the 
agastric state of this species (Verri et al., 2003). 
When the kinetic parameters are compared between paralogues transporters, 
PepT1a shows some common features with PepT1b (Table 3.1). 
Interestingly, the membrane voltage affects the K0.5 in different ways, 
according to external pH.  When the voltage became more negative at pH 
6.5, the kinetic values reported for -60 mV and for -120 mV suggest that 





not affected or slightly decrease, in zebrafish and in Atlantic salmon 
respectively. At pH 7.6 the K0.5 decreases in all PepT1 at -120 mV, with the 
greatest differences in Atlantic salmon transporters. The effects of membrane 
potential on the Imax are similar in all the proteins tested at both pH 
conditions. The ratios between Imax at -60 mV and Imax at -120 mV show 
similar values for the tested proteins (from ̴ 0.33 to ̴ 0.49) suggesting that the 
maximal relative current for zwitterionic substrates increases proportional to 
the increase in favorable electrochemical gradient. 
Analyzing the pH effect on substrate affinity, the PepT1a K0.5 is influenced 
mostly by the pH. In PepT1a transporters, the substrate amount required to 
reach one-half of the maximal currents (K0.5) increases from 6.5 to pH 7.6. 
For example, at -60 mV, the K0.5 at pH 7.6 vs. the K0.5 at pH 6.5 shows a ratio 
of   ̴ 28.83 for zebrafish and a ratio of ̴ 17.37 for Atlantic salmon. For 
PepT1b, at -60 mV, the K0.5 at pH 7.6 vs. the K0.5 at pH 6.5 shows a ratio of  ̴ 
17.07 for zebrafish and a ratio of  ̴ 2.88 for Atlantic salmon. These analytical 
data overall suggest that both PepT1a transporters have a strong pH 
dependence with respect to PepT1b (this is confirmed also by the data 
reported in Figure 3.8). 
It is generally reported that in mammalian PepT1 the decrease in external pH 
enhances the transporter apparent affinity but does not affect the maximal 
transport rate. 
E.g. in rabbit PepT1, the kinetic parameters of Gly-Gln dose response 
experiments showed that the Imax was dependent on the potential, but it was 
only modestly dependent on external pH. In contrast, the apparent K0.5 
values were dependent on both membrane potential and pH. Notably, the 
value of K0.5 at -60 mV decreased from 7.5 to 6.5 with a ratio of  ̴ 3.88 
(Kottra and Daniel, 2001). In the human PepT1, the Imax elicited by Gly-Sar 
reduced with the increase in extracellular pH and the affinity was dependent 





(Mackenzie et al., 1996b). In another study on the human transporter, it was 
shown that Imax elicited by Gly-Gln was solely dependent on membrane 
potential and essentially unaffected by pH, whereas the apparent affinity was 
modestly affected by alteration in membrane potentials and remained 
unaffected by pH. At -60mV the K0.5 at pH 7.6 vs. the K0.5 at pH 6.5 showed 
a ratio of  ̴ 0.9 (Amasheh et al., 1997). 
Comparing the effect of external pH on the kinetic parameters of fish and 
mammalian PepT1 orthologues, it is evident that in the most of the cases the 
effect on the apparent affinity are similar with an increase of the values at pH 
6-6.5, conversely a large heterogeneity is shown on the maximal relative 
currents. 
In absence of organic substrates, the PSS currents of many ion-coupled 
transporters arise from the ion-transporter interaction and are related 
qualitatively and quantitatively to the transport activity. The properties of 
PSS currents of rabbit PepT1 and zebrafish and seabass PepT1b were 
previously investigated and related to the pH dependency (Renna et al., 
2011b). In this work, the PSS currents of PepT1a transporters and of 
Atlantic salmon PepT1b were analyzed with the aim of collecting this kind of 
additional information on their transport activity.  
Overall, the transient currents of Atlantic salmon PepT1b are similar to the 
ones of zebrafish PepT1b and in general show a coherent behavior with the 
fish models currently known (Renna et al., 2011b). On the contrary, PepT1a 
transporters clearly differ from fish model while they share many 
characteristics of the transient currents with the mammalian PepT1 (Figure 
3.9). Moreover, in zebrafish PepT1a the transient currents are particularly 
slow and do not disappear (even with the concentration of 3 mmol/L of 
Gly-Gln at pH 6.5). The presence of residual PSS currents may have two 
different explanations. The first is that the substrate was not enough to 





the data highlighted by I/V relationship and its analysis in the presence of 
increasing substrate concentration (Figure 3.6). The second explanation is 
that the persistency of PSS even in the presence of the substrate is due to 
one of the two components responsible for the existence of this kind of 
currents in PepT1 transporters. In fact, the PepT1 PSS currents are 
originated both by the rearrangement of intrinsic charges of the transporter 
(Figure 4.1A), and by the movement of external protons in the electrical 
membrane field (Figure 4.1B). Recently it has emerged that in the transport 
cycle, the reorientation of transporter from the inward to the outward facing 
states is mediated by the protonation of a histidine located in an extracellular 
cavity, which is created when the transporter is in the inward open 
conformation (Parker et al., 2017).  
Through multiscale molecular dynamics (MD) simulations Parker and 
colleagues (2017) revealed that proton transport between key intracellular and 
extracellular residues can occur. Data indicate that different members of the 
POT family have developed specific mechanisms to couple transport to the 
proton gradient (Parker et al., 2017).  
The transporter structural features that guarantee the transfer of protons 
from the extracellular side of the membrane onto the histidine could be 
different in zebrafish PepT1a if compared to other PepT1 transporters. 
Therefore, the intrinsic and extrinsic components of PSS in the membrane 
electrical field of the extracellular cavity could explain the differences found 






























Figure 4.1 The model of PepT1 pre steady-state currents. A the rearrangement of the empty 
transporter between two states (1 and 2), involving the displacement of an intrinsic charge 
(yellow circles). B the extrinsic charge movement, (green circles), between the extracellular 
environment and the outside-opened transporter vestibule. In the presence of substrate (blue 
triangle), the reorientation of transporter from outward C to inward D facing states is mediated 
by the protonation of a histidine (His), located in the extracellular cavity. In D is reported the 
interaction between His and extrinsic charges in the membrane field of extracellular cavity. 
 
 
The analysis of PSS currents shows that at the same external pH, the charge vs. 
voltage (Q/V) and time constant vs. voltage (τ/V) curves are positioned on the 
voltage axis accordingly with their similarity to mammalian or to fish model 
(Renna et al., 2011b). If compared to the “fish” model, the PepT1a(s) curves are 
positively shifted, like the mammalian model, while the Atlantic salmon PepT1b 
curves are coherent with the fish model. 
 In all transporters, the change of external pH from 6.5 to 7.6 speed up the 
transient decay, shifting to more negative potential the Q/V and τ/V curves 










the membrane electrical field indicate that external protons affect the inward and 
outward rates of Atlantic salmon PepT1b. Notably, the outward rate at pH 7.6 
reaches the maximal value of about 780 s-1 , as it can be seen by the flattening of 
the curve from 0 mV to +20 mV (Figure 3.11).  
In PepT1a transporters, the acidification of the external solution does not affect 
the inward rate but strongly reduces the outward rate. The analysis on inward 
and outward rates provides an explanation for the pH and the voltage 
dependencies of the transporters apparent affinity for the Gly-Gln. 
In PepT1a transporters, the inward and outward rate at pH 6.5 cross each other 
in a range from -80 mV to -40 mV, where the maximal apparent affinity for 
Gly-Gln is observed (Figure 3.7Aa and 3.7Dd). The explanation may be that 
the major part of protonated transport proteins is in a steady-state equilibrium 
between the two different transport conformations, in this voltage range. 
Therefore, many proteins are available for the interaction with the external 
substrate and the binding equilibrium between protons and substrate will be 
reached. In such condition, the transport rate (1/τ) is the lowest; consequently, 
the transporters apparent affinity will be high, because the substrate has more 
time to bind the PepT1 proteins. At extreme voltage conditions such as in 
hyperpolarization and depolarization, the outward and inward rates are higher 
and the number of transporters in the right protonated conformation for 
substrate interaction is reduced. Therefore, higher concentrations of substrate 
are needed to produce the half maximal current. This hypothesis is supported 
also by the data at pH 7.6. In this condition, the inward and outward rates cross 
between -140 mV and -100 mV, where the maximal value of Gly-Gln affinity of 
PepT1a transporters is reached. Moreover, the strong increase of the outward 
rate from -140 mV to +20 mV causes probably the voltage dependent decrease 







To confirm the observations, the charge equilibration rate (1/τ) and Gly-Gln 
K0.5 values, collected i) at the same voltage range (from -140mV to +20 mV) and 
ii) at the same pH conditions (pH 7.6 and 6.5), are fitted with linear equation 
(Figure 4.2).  
 
Figure 4.2 Plots of rate (1/τ) versus the Michaelis Menten constant (K0.5) obtained by Gly-Gln 
dose-response experiments for zebrafish PepT1a transporter (zfPepT1a) and Atlantic salmon 
PepT1a (asPepT1a). The data points are computed using the decay rate/voltage relationship and 
the K0.5/voltage relationship at two pH conditions (pH 6.5 green square and pH 7.6 blue circle) 
and are correlated in function of membrane potentials. Straight lines are linear regression to the 
points, with the Pearson correlation coefficient (ρ) indicated. 
 
 
The Pearson correlation coefficient suggests a strongly positive correlation 
between these two parameters (the voltage dependency of 1/τ and of K0.5 is 
shown by red lines in Figure 4.2). 
Although the Gly-Gln dose response experiments for the Atlantic salmon 
PepT1b are not reported in this work because the data have already been 

























































published (Ronnestad et al., 2010), it is important to note that at both pH 
conditions 6.5 and 7.6, the K0.5 values increase from -140 mV to +20mV 
(Figure 4.3A and 4.3Aa).  
In Atlantic salmon PepT1b, the behavior of both unidirectional rate constants 
shows that they have the slowest value at hyperpolarized voltage and that they 
accelerate moving toward the more positive voltage, at both pH conditions. The 




Figure 4.3 In A Atlantic salmon PepT1b K0.5 values at each indicated voltage and at pH 6.5 
(green square) and 7.6 (blue circle). The data are obtained by Gly-Gln dose-response 
experiment. The inserts (Aa) is enlargements of K0.5 at pH 6.5. In B Plots of rate (1/τ) versus 
the Michaelis Menten constant (K0.5) for Atlantic salmon PepT1b. The data points are 
computing using the decay rate/voltage relationship and the K0.5/voltage relationship at two pH 
conditions (pH 6.5 green square and pH 7.6 blue circle) and are correlated in function of 
membrane potentials. Straight lines are linear regression to the points, with the Pearson 
correlation coefficient (ρ) indicated. 
 
 
























































Comparing the parameters of the Boltzmann equation (see Table 3.3), the 
maximal moveable charge Qmax values measured for zebrafish PepT1a are the 
highest at all pH conditions and, differently from the others, zebrafish Qmax 
increase with the increase of external pH. Conversely, the lowest Qmax values are 
obtained by the analyses on the PSS currents of zebrafish PepT1b. The Atlantic 
salmon transporters show similar values of the maximal moveable charge. For 
all transporters, the alkalization of external medium causes a shift to more 
negative values of the voltage needed to move half of the charge (V0.5). This 
effect is more evident in rabbit PepT1 with a ratio of  ̴ 2.42 and in zebrafish and 
Atlantic salmon PepT1a transporters with ratios of  ̴ 1.91 and  ̴ 2.14, 
respectively. The same effect is very faintly detectable in PepT1b with very small 
differences between the two pH.  
Several studies documented that not only neutral dipeptides but also dipeptides 
carrying net positive or negative charge are able to induce inward currents via 
PepT1 (Amasheh et al., 1997; Kottra et al., 2002; Verri et al., 2010).  
Although it is still controversial how PepT1 handles differently charged 
substrates together with H+ and with which stoichiometry, the transport of 
positive and negative charged dipeptides is an electrogenic process that follows 
the Michaelis-Menten kinetics. Moreover, electrophysiological studies on rabbit 
and zebrafish transporters reported that the position of the charged amino acid 
chain in a substrate significantly affects the transport process.  
To investigate whether similar differences may be observed in zebrafish PepT1a 
and in Atlantic salmon transporters, the transport current of 1 mmol/L of 
negatively charged dipeptides (Asp-Gly and Gly-Asp) and two pairs of positively 
charged dipeptides (Lys-Gly and Gly-Lys; Lys-Met and Met-Lys) were recorded 
and compared each other (Figure 3.12). 
Transport currents recorded i) at fixed membrane potential of -60 mV and ii) at 
pH 7.6 and normalized to the current of the reference substrate (Gly-Gln), show 





negative charged dipeptides depend on the position the charged amino acid in 
PepT1a(s) but not in PepT1b transporters. Conversely, the position of the 
charge residue in positive substrates defines the current amplitudes in Atlantic 
salmon PepT1b. This effect was observed also in rabbit PepT1, in seabass 
PepT1 and zebrafish PepT1b, even if in this latter only for the pair Lys-Gly and 
Gly-Lys (Margheritis et al., 2013). 
In PepT1a, the currents elicited by dipeptides with a positive residue are 
definitely smaller for both orthologues (less than 20% in zebrafish for all 
dipeptides and in Atlantic salmon for Lys-Gly and Gly-Lys). In this last case, the 
transport currents of Lys-Met and Met-Lys are reduced to around 50% of Gly-
Gln current. The position of the positive residue in the dipeptide marginally 
influences the transport activities of PepT1a transporters.  
In zebrafish PepT1a, when the negative charge is in the amino-terminal position 
(Asp-Gly) the transport current increases (Figure 3.12A) and is greatly 
influenced by the voltage (Figure 3.13A). In Atlantic salmon PepT1a, Asp-Gly 
elicits larger current than the reference peptide Gly-Gln in a limited voltage 
range around to -60 mV. At -140 mV a slight decrease of current is recorded 
with respect to the current due to Gly-Gln.  For both PepT1a transporters, 
when the negative charge is in carboxyl-terminal position (Gly-Asp) the 
transport currents are similar to the reference Gly-Gln current (Figure 3.12A 
and Figure 3.13A). In PepT1b, the negatively charged substrates elicit current 
that are always smaller than the reference Gly-Gln current at all tested voltages, 
particularly in zebrafish, where the relative currents are very small (Figure 3.12A 
and 3.13A). 
The different transport current amplitudes between PepT1a and PepT1b in the 
presence of negatively charged substrate are probably due to differences in the 
amino acid residues involved in substrate and/or in proton binding. It is 
reported that negatively charged dipeptides are transported in uncharged form, 





of the membrane and thus translocated virtually as charged species together 
with two protons (Kottra et al., 2002). At pH 7.6 less than 1% of Asp-Gly and 
of Gly-Asp are present in the electrical neutral form. Thus, the largest inward 
current recorded for Asp-Gly but not for Gly-Asp in PepT1a(s) could be 
ascribed to the easy protonation of the negatively charged form in the proximity 
of the binding site as function of the charge position in the dipeptide.  
This last hypothesis could explain the different current amplitudes of Asp-Gly 
between zebrafish PepT1a and PepT1b, when the values of Qmax are considered. 
Although it is thought that the PepT1 transporter PSS are mostly due to the 
rearrangement of intrinsic transporter charges (Renna et al., 2011b), the 
involvement of the external proton movements in the electrical membrane field 
is considered partly responsible of the PSS genesis. Thus, at pH 7.6 for 
zebrafish PepT1a, the highest value of Qmax (53.0 ± 0.6 nC) could be due to an 
increase in protons entering the open vestibule of the transporter that might 
increase the Asp-Gly protonation and thus its transport as charged substrate. 
Conversely, for zebrafish PepT1b, the smallest value of Qmax (9.9 ± 1.1 nC) 
could explain the negligible transport current in the presence of Asp-Gly 
together with the low relative affinity for this dipeptide (K0.5 at pH 7.5 is 13 ± 1 
mmol/L for Asp-Gly vs. 1.44 ± 1.18 mmol/L for Gly-Gln) (Verri et al., 2009). 
Preliminary data on kinetic transport parameters of Gly-Asp in zebrafish 
PepT1a are reported in Table 3.4. The percentage of the negative charged 
dipeptide Gly-Asp in neutral form increase from <0.1 to 8% upon a pH 
reduction from 7.5 to 5.5. In rabbit PepT1 and in zebrafish PepT1b, it was 
reported that the reduction of pH led to a marked increase in binding affinity 
(ratio: ̴ 39 in rabbit and ̴ 100 in zebrafish PepT1b), whereas the simultaneous 
changes in Imax were only moderate in both transporters (ratio: ̴ 0.7). Notably, 
changing the external pH from 7.5 to 5.5 an increase in Imax occurred in rabbit 
PepT1 while a decrease in Imax is observed in zebrafish PepT1b, according with 





7.6 to 5.5, the apparent affinity increases (ratio: ̴ 22), whereas a marked decrease 
in Imax is reported (ratio: ̴ 2.3). Data on Gly-Asp kinetic parameters of zebrafish 
PepT1a suggest that at pH 5.5 the substrate apparent affinity is similar between 
PepT1a (K0.5 0.27 ± 0.03 mmol/L) and PepT1b (K0.5   0.21 ± 0.03 mmol/L, see 
Verri et al., 2010). When the external pH is increased at 7.5/7.6, the apparent 
affinity decreases in both transporters: in PepT1a with K0.5 5.89 ± 2.14 mmol/L 
and in PepT1b, more strongly, to a K0.5  21 ± 5 mmol/L, (Verri et al., 2009). 
The results on the transport currents of positive charged substrates reveal that 
in Atlantic salmon PepT1b the substrates carrying the charged residue in amino 
terminal position (Lys-Gly and Lys-Met) elicits larger currents than Gly-Gln and 
the reversed dipeptides (Gly-Lys and Met-Lys) (Figure 3.12B and 3.12C). The 
I/V relationship for Atlantic salmon PepT1b shows a larger Lys-Gly transport 
current and a smaller current in the presence of Gly-Lys if compared to the Gly-
Gln current (Figure 3.13B). 
Although in zebrafish PepT1b the Lys-Gly current is larger than Gly-Lys, both 
substrates elicit currents that are smaller than the reference current (Figure 
3.12B) at all the tested voltages (Figure 3.13B). Data obtained by the transport 
activity of zebrafish PepT1b show comparable currents between Met-Lys, Lys-
Met and Gly-Gln (Figure 3.13C). 
For both PepT1a transporters, the currents in the presence of the four positively 
charged substrates are smaller than the reference current (Figure 3.12B and 
3.12C). Moreover, the I/V relationships for Lys-Gly and Gly-Lys clearly show 
that these substrates are almost unable to elicit significative currents in the range 
of tested voltage (Figure 3.13B). 
In rabbit PepT1, the electrophysiological recordings combined with 
simultaneous intracellular pH measurement under voltage clamp condition 
showed that the Lys-Gly can be transported both in charged and neutral form 
(Kottra et al., 2002), whereas the Gly-Lys is transported in neutral form. 





Lys-Gly and Gly-Lys could be due to differences in substrate affinity, the results 
from the rabbit transporter could explain the excess in transport current 
observed in Atlantic salmon PepT1b for Lys-Gly.  
Moreover, the Lys-Gly dose response experiments highlight the difference in 
transport kinetics between Atlantic salmon PepT1a and PepT1b. The fitting 
with the Michaelis-Menten equation allows the computation of the kinetic 
parameters (K0.5 and Imax) at each voltage for PepT1b (Figure 3.17A and 13.7B), 
but not for PepT1a.  In this experiment, the current recorded in PepT1a does 
not reach the saturation (Figure 3.16A), and residual PSS currents are visible 
even with perfusion of Lys-Gly 30 mmol/L (Figure 3.16C), making the 
evaluation of the kinetic parameters not reliable. In zebrafish transporters, the 
comparison between K0.5 values at the same experimental conditions (pH 7.6 
and at -60 mV) show that PepT1b transports Lys-Gly with an affinity five-fold 
higher (K0.5 3.5 ± 0.6 mmol/L see Verri et al., 2009) than PepT1a (K0.5 18.35 ± 
3.51) (Table 3.4). Moreover, when the external pH is increased from 7.5/7.6 to 
8.5 the percentage of the positively charged Lys-Gly molecules decreases from 
83 to 33% and the kinetic parameters are differently influenced in PepT1b and 
PepT1a transporters. Zebrafish PepT1b shows a decrease in relative affinity 
(ratio: ̴ 0.2) but an increase in maximal relative current (ratio: ̴ 0.6), whereas 
PepT1a shows an increase in affinity (ratio: ̴ 1.6) but the simultaneous change in 
maximal relative current is only moderate (ratio: ̴ 1.1).  
Transport data on Lys- and Met- containing substrates have been also evaluated 
to better investigate the role of each transporter in nutrition. Applying a pulse 
protocol, the transport current of 1 mmol/L of each dipeptide are measured at 
pH 6.5 and 7.6 and compared to investigate both voltage and pH dependency 
(Figure 3.14). The same experimental procedure was applied by Margheritis and 
collaborators in 2013 to collect transport current of zebrafish PepT1b, seabass 
PepT1 and mammalian transporters (Margheritis et al., 2013). When the results 





relationships of Lys-Gly show a similar behavior to that found in zebrafish 
transporter, whereas the I/V relationships of Met-Lys and Lys-Met appear to be 
similar to those observed in seabass and mammalian transporters (Margheritis et 
al., 2013). When the current amplitudes are compared between PepT1a and 
PepT1b transporters of each species, the highest values are obtained from 
PepT1b. These results suggest the low involvement of PepT1a in the transport 
of these important nutritional dipeptides. 
Summarizing in PepT1a transporters, dipeptides containing lysine and/or 
methionine show currents that are smaller than the reference current, for all the 
tested potentials and pH conditions. Conversely, large currents are shown in 
Atlantic salmon PepT1b for all the tested substrates with the only exception of 
Gly-Lys. These currents are influenced by membrane potential and by the 
position of charge residue in dipeptide. 
Particularly in zebrafish PepT1a transporter, the currents elicited by all of the 
tested substrates are slightly increased by membrane potentials and by different 
pH conditions. In Atlantic salmon PepT1a, the transport current is augmented 
by increasing negative potential only in the presence of methionine containing 
dipeptides with a peculiar pH dependency. In Atlantic salmon PepT1b, large 
currents are observed in the presence of dipeptides carrying the lysine in N-
terminus position at the more negative potentials and at external pH 7.6. 
These data on charged substrate have a dual importance. First, these evidences 
have major importance in animal nutrition being lysine an essential amino acid; 
secondly, the information about the ability of PepT1 to transport charged amino 
acid is crucially useful in modelling the steps of translocation of charged 








Chapter 5. Conclusions 
 
 
This thesis work describes the novel evidence that PepT1a-type proteins of 
teleost fish are functional transporters that work as a proton depended, sodium 
independent system for the uptake of di- and tripeptides. Similar to the 
paralogues PepT1b, both zebrafish and Atlantic salmon PepT1a transporters are 
low affinity and high capacity systems that show kinetic parameters influenced 
by voltage and external pH. The unique pH dependency of the zebrafish 
PepT1b transporter is confirmed also for PepT1a. This functional peculiarity 
strongly supports the use of PepT1 orthologues of zebrafish as tools for a 
detailed analysis of residues and domains involved in the proton-protein 
relationships. 
Although a cursory comparison shows species-specific conserved features in 
basic transport function, detailed analysis on steady-state and PSS currents show 
differences between PepT1a and PepT1b transporters of each species that are 
correlated strictly to the differences in amino acids sequences. These differences 
emerge analyzing the current response for different externally definable 
parameters such as substrate concentration, pH and membrane potentials.  
Since the transport kinetics are thought to result from a series of molecular 
rearrangements between multiple conformational states, the results reported 
here suggest that differences in structural-functional relationships exist between 
the transporters analyzed in this work. 
In this perspective, the functional characterization of teleost fish orthologues 
represents an important starting point to define better the relation between 
structure and function of PepT1-type proteins.  
Considering the increase in structural information from the crystal structures of 
bacterial transporters, it is possible to perform a comprehensive analysis of the 





to identify residues that are involved in distinct phases of the transport cycle and 
to explain also how these residues may be critical in determining the diversified 
behaviors of PepT1 orthologues. 
Moreover, the data about the transport currents elicited by charged substrates or 
by important nutritional substrates highlight strong differences between PepT1a 
and PepT1b transporters, giving the opportunity to define the determinants 
possibly involved in the interaction with charged substrates.  
When PepT1a and PepT1b transporters are contemporarily expressed in the 
same tissue, the functional differences suggest that they might operate 
synergistically to achieve the optimal absorption of protein degradation 
products, further implying physiological roles based on the differential 
interaction with different substrate peptides. Indeed, the expression of PepT1 in 
the enteroendocrine cells supports the possible physiological role as nutrient 
detector/sensor. 
All data presented in this thesis will be useful not only to study and specify the 
physiological role(s) in peptide transport and/or sensing in fish, but also to give 
new insights about unsolved questions on the kinetic mechanism of PepT1-
mediated transport. Moreover, the increasing use of teleost fish as animal 
models in translational research demands deep information on the physiology of 
these organisms. For instance, the studies of intestinal inflammatory diseases, 
metabolic disorders and cancers in which PepT1 is involved directly or 
indirectly, require a detailed knowledge of the function of different orthologues 
transporters. Additionally, the functional data can support the therapeutic 
approach because PepT1 is important not only as main route in oral drug 
delivery but also as pharmacological target. These aspects require a detailed 
analysis of protein-substrate interactions from the structural as well as kinetic 
and functional points of view. The comprehension of the molecular basis of the 






To conclude, the study of PepT1 based on comparative approaches could be 
useful to better clarify its role in the complex scenario of sensing and absorption 
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                                 <----------I---------->                   <----------II-- 
   PepT1a      MPDSKMDETKKKKKKTAECCGYPISIFFIVVNEFCERFSYYGMRAVLVLYFRYFLLWDDDLATSIYHAFVALCYL    75 
   PepT1b      ~~~MADKEGHKQKKERASCFGYPVSIFFIVVNEFCERFSYYGMKAVLVLYFKYFIGWDDDLSTTIYHTFVALCYL    72 
                                                    <---------I-------->         <-------- 
 
               ------->           <---------III--------->         <----------IV--------->  
   PepT1a      TPILGAIIADSRLGKFKTIIYLSIVYAVGQVVMAVSTIHDITDANRDGTPDNFTLHIALSMLGLVLIALGTGGIK   150 
   PepT1b      TPIMGAIIADSWLGKFKTIVYLSIVYTIGQVIMAISAIHDITDANRDGKPDNKTLHISLSMLGLILIALGTGGIK   147 
               --II--------->    <---------III--------->                   <----------IV-- 
 
                                 <----------V---------->                   <----------VI-- 
   PepT1a      PCVAAFGGDQFQEHQSRQLNTFFSVFYLCINAGSLLSTLITPVLRAQECGIHTQQQCYPLAFGVPAALMVVSLVV   225 
   PepT1b      PCVAAFGGDQFEDHQEKQRSTFFSIFYLSINAGSLLSTLITPILRSQECGIYAKQSCYPLAFGVPAALMVVALIV   222 
               ------->            <----------V---------->              <----------VI----- 
 
               ------->                                                <---------VII------ 
   PepT1a      FIAGSGMYTKTAPEGNIMGSVCKCIWFALNNRFRHRSDIYPKREHWMDWAEEKYDKLLIAQIKMVLKVLFLYIPL   300 
   PepT1b      FVIGHKMYIMESPKGNILLQVINCIGFALNNRFRHRGKQYPKREHWMDWAEEKYDKLLIAQVKMVVKVLFLYIPL   297 
               ---->                                                   <---------VII------ 
 
               --->                               <---------VIII-------->            <---- 
   PepT1a      PMFWTLFDQKGSRWTLQATTMTGDFGGFVLQPDQMQTVNPILILTLVPIMDRIVFPLIKKCGLNFSPLKRMTVGM   375 
   PepT1b      PMFWALFDQQGSRWTIQATTMDGNFGGFVIQPDQMQIVNPILIVIMVPIMDSAIYPLIKLCRINFTPLRKMTVGM   372 
               --->                               <---------VIII-------->            <---- 
 
               ---IX------->                                                               
   PepT1a      LFAATAFIAAALVQMEVDKTLPNFPSSSESQLKVVNMHSESLIVTVPSQEPLLIGSFESSPDYITFGQQDIRLAF   450 
   PepT1b      VLAALAFVAAALLQLQIDETMPKFPSTSQTQLKFLNVESTSLPVVVEGQDQFMVPGFNASSEYLTLDKENVTISA   447 
               ------IX--------->                                                          
 
                                                                                           
   PepT1a      YTTPAINKDLSLIKGSRQTLIIPSEPAEMYLKEDIKSKPKEGKNAVRFVNGWTAYLNITNLES--SLQPSETSNY   523 
   PepT1b      ---GGVNDTAFLKTGTRHTVLMNAA-GMRNTLDDLTEKPEQGLNAIRFVNGWENRLNVSVKSDNVHADPLDASVY   518 
                                                                                           
 
                                                                             <----------X- 
   PepT1a      TLVSQGMRKFTLT-NGIQSCEFSRKFGFGSSYTFLIPSDLF-STD-CESIKEIEDMQPNSVHMALQIPQYFLITT   595 
   PepT1b      LLVPHGKVNFTIFDGGDGKCHYIMQLGFGSTYTVLIPSTFAFGQTCSESFEAVQDMEPNRIHMAWQVIQYFLLTC   593 
                                                                             <----------X- 
 
               --------->             <----------XI--------->         <---------XII------- 
   PepT1a      GEVMFSVTGLQFSYSQAPKNMKSVLQAGWLCTNAVGNIIVLIVAELGKLPKQWAEYVLFASLLVAVSIIFSIMAY   670 
   PepT1b      GEVVYSVTGLDFSYSQAPSNMKSVLQAGWLLTVAVGNIIVLIVAEAGSLPDQWAEYLLFASLLVAVSIIFAIMAY   668 
               --------->              <--------XI-------->            <---------XII------ 
 
               -->                                                    
   PepT1a      FYTYIDPAEIEAEILKQQETDPDKKKKKETLEMEEKEN-------EQEIKQTKI   717 
   PepT1b      FYTYIDPNEIEAKFKELE---PEDKKRKE-MQMTAKDNMAYVHNENTNIKQTKI   718 
               --->                                                   
 
 
Figure S.1 Pairwise alignment between zebrafish PepT1a (Slc15a1a) and PepT1b (Slc15a1b) 
amino acid sequences obtained by using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/)(Sievers et al., 2011) and edited using GeneDoc 
2.7 software. The predicted (https://prosite.expasy.org/scanprosite/) (Hulo et al., 2006) 
conserved PTR2 family proton/oligopeptide symporters signatures (in zebrafish PepT1a, motif 
1 - PROSITE pattern PS01022 - amino acid residues 80-104; and motif 2 - PROSITE pattern 
PS01023 - amino acid residues 173-185) are colored in purple. In the amino acid sequence, 
putative transmembrane domains are named I to XII. Weak predicted transmembrane domains 







                                                <--------I------->         <----------II-- 
   PepT1a      MTDEEVVKKGKSKEVCGYPLSIFFIVVNEFCERFSYYGMRAVLVLYFRYFLRFDDDLATSIYHTFVALCYLTPIL    75 
   PepT1b      MTDIDVKKSKRKVDVCGYPLSIFFIVVNEFCERFSYYGMRAVLVLYFRYFLKWDDDLSTSIYHTFIALCYLTPIL    75 
                                                <--------I------->         <----------II-- 
 
               ------->      <--------III------->              <----------IV---------> 
   PepT1a      GAVVADSWLGKFKTIIYLSIVYAIGQVVMAVSAIHDITDTDRDGTPDNLTLHIVLSMVGLLLIALGTGGIKPCVA   150 
   PepT1b      GAIVADSWLGKFKTIVYLSIVYTVGQVVMAVSAIHDITDTDRDGTPDNMTFHVAMSMVGLFLIALGTGGIKPCVA   150 
               ------->      <---------III--------->                   <----------IV------ 
 
                               <----------V---------->              <----------VI--------- 
   PepT1a      AFGGDQFQDHQAKQRSTFFSVFYLCINGGSLLSTIITPILRGQECGIHSQQKCYPLAFGVPAALMVVALVVFIIG   225 
   PepT1b      AFGGDQFEEHQEKQRSTFFSIFYLSINAGSLLSTVITPILRGQECGIHSQQKCYPLAFGVPAALMVVALIVFIMG   225 
               --->            <----------V---------->              <----------VI--------- 
 
               >                                                   <---------VII---------> 
   PepT1a      SGMYHKTEPQGNIMLDVCKCIGFAVKNRFRHRSSSYPKRTHWMDWAEEKYEKLLIAQIKMVLKVLFLYIPLPMFW   300 
   PepT1b      SGMYNKTAPKGNIMLEVCKCIGFAVKNRFRHRSKKFPKREHWMDWADEKYDKLLVAQVKMVLKVMFLYIPLPMFW   300 
               >                                                   <---------VII---------> 
 
                                              <---------VIII-------->            <-------- 
   PepT1a      TLFDQKGSRWTLQATTMDGNFGSLILQPDQMQTVNPILILTLVPIMDSVVYPLIKKCGLNFTPLRRMTVGMFLAA   375 
   PepT1b      TLFDQQGSRWTLQATTMDGNFGILTVQPDQMQTVNPILILALVPIMDSLVYPLIKKCHLNFTPLKRMTVGMLIAA   375 
                                              <---------VIII-------->            <-------- 
 
               IX--------> 
   PepT1a      MAFVAAALVQIQIDKTLPTFPSSSQSQLKLLNMGSIPLTVTLPNNDPFVIEAAKANANYLTFEEESINVSLQSPA   450 
   PepT1b      LAFVAAALLQLQIDQTLPKLPQGVAGQVKFLNLNSAPLTLTIDGTIDVSVPAHQVNTGDYLTFDKSVRVVFNKNT   450 
               IX--------> 
 
   PepT1a      ISRTISLAKGKRQTLLIPSNLSAPMWEMTDDLMAKPEQGANAIRFVNGMAGAVNVSTFGSIEYSSASNYSLISNG   525 
   PepT1b      STGTDLILMSQTRRTALVSPTLDMNLVYDLSKKPDDGMNAIRFVNGLGSALNVTLGVGDIAPLAVSNYSLVPQGK   525 
 
                                                                           <----------X--- 
   PepT1a      KATFTITNGANTCEYSREFGFGSSYTLLIPSHFAWG-LTCSESISGVEDIQPNSFHMGWQIPQYFLITCGEVVFS   599 
   PepT1b      AEFTIMNSGGASCLYSIDLGFGSAFTLLIPSTFTIGSPDCWQAIQVVEDIQPNTIHMGWQIPQYFLMTGGEVVFS   600 
                                                                           <----------X--- 
 
               ------->            <--------XI-------->         <---------XII---------> 
   PepT1a      VTGLEFSYSQAPSNMKAVLQAGWLFTVAIGNFIVLIVAEIAQIEEQWAEFVLFASLLVAVCVIFSIMAYFYTYMD   674 
   PepT1b      VTGLEFSYSQAPSNMKSVLQAGWLFTVAVGNIIVLIVAEAAQLPDQWAEYILFASLLVVVCIVFAIMSYFYTYTD   675 
               ------->            <--------XI-------->         <---------XII---------> 
 
   PepT1a      PAEIEAQFTDNGGKEESDKEELQMQKKD-----------------VVDHHNEDDEAKQTKM   718 





Figure S.2 Pairwise alignment between Atlantic salmon PepT1a (Slc15a1a) and PepT1b 
(Slc15a1b) amino acid sequences obtained by using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al., 2011) and edited using GeneDoc 
2.7 software. The predicted (https://prosite.expasy.org/scanprosite/) (Hulo et al., 2006) 
conserved PTR2 family proton/oligopeptide symporters signatures (in Atlantic salmon PepT1a, 
motif 1 - PROSITE pattern PS01022 - amino acid residues 76-100; and motif 2 - PROSITE 
pattern PS01023 - amino acid residues 169-181) are colored in purple. In the amino acid 
sequence, putative transmembrane domains are named I to XII. 
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